<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">99735</article-id><article-id pub-id-type="doi">10.7554/eLife.99735</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.99735.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Unraveling CRP/cAMP-mediated metabolic regulation in <italic>Escherichia coli</italic> persister cells</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ngo</surname><given-names>Han G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3860-4550</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Mohiuddin</surname><given-names>Sayed Golam</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7613-6324</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ananda</surname><given-names>Aina</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Orman</surname><given-names>Mehmet</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-8499-9154</contrib-id><email>morman@central.uh.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/048sx0r50</institution-id><institution>Department of Chemical and Biomolecular Engineering, University of Houston</institution></institution-wrap><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01d6qxv05</institution-id><institution>Department of Biology, Monmouth University</institution></institution-wrap><addr-line><named-content content-type="city">West Long Branch</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Kornmann</surname><given-names>Benoit</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Kornmann</surname><given-names>Benoit</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/052gg0110</institution-id><institution>University of Oxford</institution></institution-wrap><country>United Kingdom</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>08</day><month>07</month><year>2025</year></pub-date><volume>13</volume><elocation-id>RP99735</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-06-10"><day>10</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-06-10"><day>10</day><month>06</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.06.10.598332"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-09-04"><day>04</day><month>09</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99735.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2025-06-26"><day>26</day><month>06</month><year>2025</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99735.2"/></event></pub-history><permissions><copyright-statement>Â© 2024, Ngo et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Ngo et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-99735-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-99735-figures-v1.pdf"/><abstract><p>A substantial gap persists in our comprehension of how bacterial metabolism undergoes rewiring during the transition to a persistent state. Also, it remains unclear which metabolic mechanisms become indispensable for persister cell survival. To address these questions, we directed our efforts towards persister cells in <italic>Escherichia coli</italic> that emerge during the late stationary phase. These cells have been recognized for their exceptional resilience and are commonly believed to be in a dormant state. Our results indicate that the global metabolic regulator Crp/cAMP redirects the metabolism of these antibiotic-tolerant cells from anabolism to oxidative phosphorylation. Although our data demonstrates that persisters exhibit a reduced metabolic rate compared to rapidly growing exponential-phase cells, their survival still relies on energy metabolism. Extensive genomic-level analyses of metabolomics, proteomics, and single-gene deletions consistently highlight the critical role of energy metabolism, specifically the tricarboxylic acid (TCA) cycle, electron transport chain (ETC), and ATP synthase, in sustaining persister levels within cell populations. Altogether, this study provides much-needed clarification regarding the role of energy metabolism in antibiotic tolerance and highlights the importance of using a multipronged approach at the genomic level to obtain a broader picture of the metabolic state of persister cells.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd><italic>E. coli</italic></kwd><kwd>persisters</kwd><kwd>energy metabolism</kwd><kwd>Crp/cAMP</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000001</institution-id><institution>National Science Foundation</institution></institution-wrap></funding-source><award-id>2044375</award-id><principal-award-recipient><name><surname>Orman</surname><given-names>Mehmet</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI143643</award-id><principal-award-recipient><name><surname>Orman</surname><given-names>Mehmet</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>CRP/cAMP plays a crucial role in the metabolic shift of <italic>Escherichia coli</italic> persisters from an anabolic state to oxidative phosphorylation, which is essential for their survival during antibiotic treatment.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Bacterial persisters within cell cultures constitute a small subpopulation of cells exhibiting a transient antibiotic-tolerant state (<xref ref-type="bibr" rid="bib10">Balaban et al., 2004</xref>). While persisters have traditionally been characterized as non-growing and dormant phenotypes (<xref ref-type="bibr" rid="bib36">Lewis, 2010</xref>), recent studies challenge these conventional hallmarks, revealing the heterogeneity of persister cells in terms of growth, metabolism, and other cellular activities (<xref ref-type="bibr" rid="bib1">Adams et al., 2011</xref>; <xref ref-type="bibr" rid="bib7">Arnoldini et al., 2014</xref>; <xref ref-type="bibr" rid="bib24">Hossain et al., 2023</xref>; <xref ref-type="bibr" rid="bib40">Ma et al., 2010</xref>; <xref ref-type="bibr" rid="bib48">Mok et al., 2015b</xref>; <xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="bib63">Shan et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Wakamoto et al., 2013</xref>). Despite potential discrepancies in research outcomes in the field, we think that these variations arise from the intricate and diverse survival mechanisms employed by bacterial cells in response to adverse conditions, such as antibiotic treatments. Furthermore, the interplay of stochastic and deterministic factors associated with these mechanisms adds another layer of complexity, with outcomes highly contingent on factors such as cell types, antibiotics, and experimental and growth conditions (<xref ref-type="bibr" rid="bib43">Michiels et al., 2016</xref>). The persistence phenomenon presents a significant health concern (<xref ref-type="bibr" rid="bib25">Huemer et al., 2020</xref>; <xref ref-type="bibr" rid="bib50">Murray et al., 2022</xref>), as the transient antibiotic-tolerant state of persister cells promotes recurrent infections (<xref ref-type="bibr" rid="bib19">Fisher et al., 2017</xref>) and establishes them as a reservoir for the emergence of antibiotic-resistant mutants (<xref ref-type="bibr" rid="bib11">Barrett et al., 2019</xref>; <xref ref-type="bibr" rid="bib35">Levin-Reisman et al., 2017</xref>; <xref ref-type="bibr" rid="bib76">Windels et al., 2019</xref>).</p><p>Drug tolerance is a widespread phenomenon observed in both prokaryotic and eukaryotic cell types. Otto Warburgâs research in the early 20th century unveiled an intriguing aspect of mammalian cell metabolism known as âaerobic glycolysisâ, wherein proliferating cells (e.g. tumor cells) derive energy predominantly through glycolysis, even in the presence of oxygen (<xref ref-type="bibr" rid="bib75">Warburg, 1925</xref>). This metabolic reprogramming involves restricting entry into the tricarboxylic acid (TCA) cycle through precise enzymatic control, diverting glycolytic intermediates towards anabolic pathways. This adaptation supports the extensive biosynthesis required for active cell proliferation in tumors (<xref ref-type="bibr" rid="bib22">Hanahan and Weinberg, 2011</xref>). Remarkably, tumorigenic persisters that exist in a non-proliferating state may not primarily depend on aerobic glycolysis. Instead, there is substantial evidence suggesting that these cells rely on energy metabolism (<xref ref-type="bibr" rid="bib59">Porporato et al., 2018</xref>; <xref ref-type="bibr" rid="bib71">Vasan et al., 2020</xref>); however, the presence of this metabolic state in antibiotic-tolerant bacteria is still a question mark (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). Reprogramming energy metabolism seems to be an evolutionarily conserved strategy for cells facing stress or adverse conditions, as these cells might benefit from the significantly higher ATP production efficiency provided by oxidative phosphorylation (<xref ref-type="bibr" rid="bib22">Hanahan and Weinberg, 2011</xref>). The identification of a mechanism shared by diverse cell types could open avenues for the development of global strategies to target drug-tolerant cells effectively.</p><p>A recent study suggests that bacterial persisters constitute a stochastically formed subpopulation of low-energy cells, despite some observed overlap in ATP levels between antibiotic-sensitive and persister cells (<xref ref-type="bibr" rid="bib42">Manuse et al., 2021</xref>). The persister cells examined in that study were derived from an aged stationary phase culture (48 hr post-inoculation; <xref ref-type="bibr" rid="bib42">Manuse et al., 2021</xref>), a condition known to elevate the number of non-growing cells, which do not promptly resume growth upon transfer to a fresh medium (<xref ref-type="bibr" rid="bib45">Mohiuddin et al., 2020b</xref>). While the non-growing cells formed during the stationary phase have reduced metabolic activity compared to growing cells, as demonstrated in our earlier study (<xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>), they still exhibit a certain degree of respiratory activity (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). In a recent study measuring ATP levels in viable but non-culturable (VBNC; a phenotype that is antibiotic tolerant but unable to resume growth after antibiotic removal), persister and antibiotic-sensitive cells from 24 hr stationary phase cultures, a significant overlap in intracellular ATP concentrations was observed between antibiotic-sensitive and persister cells (<xref ref-type="bibr" rid="bib37">Li et al., 2024</xref>). On the other hand, VBNC cells exhibited drastically lower ATP levels compared to both persister and antibiotic-sensitive cells (<xref ref-type="bibr" rid="bib37">Li et al., 2024</xref>). Another independent study, which utilized single-cell analysis, reported that ofloxacin persisters were metabolically active cells in exponentially growing cultures before treatment, and these cultures were obtained from 16 hr overnight precultures (not aged; <xref ref-type="bibr" rid="bib20">Goormaghtigh and Van Melderen, 2019</xref>). These findings suggest that while persisters formed during exponential growth may initially retain metabolic activity, they may gradually transition to reduced energy states as they age within the culture. The nature of persister-cell metabolism in bacteria is a topic that has long been a point of contention in scientific circles. The controversy surrounding this topic primarily arises from studies that rely on bacteriostatic chemicals or a limited number of gene deletions, or direct comparisons to exponentially growing cells, all of which have inherent drawbacks (<xref ref-type="bibr" rid="bib14">Conlon et al., 2016</xref>; <xref ref-type="bibr" rid="bib42">Manuse et al., 2021</xref>; <xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). The metabolism of persister cells, a very complex phenomenon, cannot be easily characterized by a simplistic term such as âmetabolic dormancyâ. Even if persister cells may exhibit a lower metabolism compared to the vast majority of rapidly growing exponential-phase cells, they may still rely on energy metabolism for their functioning (<xref ref-type="bibr" rid="bib6">Amato et al., 2014</xref>; <xref ref-type="bibr" rid="bib60">Prax and Bertram, 2014</xref>). In fact, analyzing published studies collectively suggests that bacterial cell metabolism undergoes intricate alterations or rewiring as they transition into a tolerant state, and these alterations seem to be highly dependent on the specific conditions tested (<xref ref-type="bibr" rid="bib1">Adams et al., 2011</xref>; <xref ref-type="bibr" rid="bib7">Arnoldini et al., 2014</xref>; <xref ref-type="bibr" rid="bib40">Ma et al., 2010</xref>; <xref ref-type="bibr" rid="bib48">Mok et al., 2015b</xref>; <xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="bib63">Shan et al., 2015</xref>; <xref ref-type="bibr" rid="bib73">Wakamoto et al., 2013</xref>).</p><p>To gain a better understanding of the critical role of energy metabolism in persister cell survival, we have focused our research on antibiotic-tolerant cells formed during the stationary phase, given that these cells are known to be highly resilient and capable of surviving a variety of stressors, including antibiotics, and are assumed to be dormant (<xref ref-type="bibr" rid="bib10">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). These cells are also referred to as type I persisters, which cannot readily resume growth when diluted in fresh media during the lag phase (<xref ref-type="bibr" rid="bib10">Balaban et al., 2004</xref>). Previous studies showed that these persister cells can metabolize specific carbon sources that make them susceptible to aminoglycosides (AG) (<xref ref-type="bibr" rid="bib4">Allison et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">Mok et al., 2015a</xref>; <xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>). Their AG susceptibility is due to increased AG uptake, which is facilitated by increased electron transport chain (ETC) activity and membrane potential (<xref ref-type="bibr" rid="bib4">Allison et al., 2011</xref>). The presence of active energy metabolism in antibiotic-tolerant, non-growing cells may indeed explain their rapid killing by AG in the presence of carbon sources (<xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). When the knockout strains of global transcriptional regulators (i.e. ArcA, Cra, Crp, DksA, Fnr, Lrp, and RpoS) were screened using the AG potentiation assay in our previous study. The results showed that the panel of carbon sources tested potentiated the AG killing of tolerant cells derived from most knockout strains, except for Î<italic>crp</italic> and Î<italic>cyaA</italic> (<xref ref-type="bibr" rid="bib47">Mok et al., 2015a</xref>). This can be attributed to the lack of active energy metabolism in these mutant strains, as the Crp/cAMP potentially shapes persister cell metabolism during the stationary phase. Depletion of primary carbon sources activates adenylate cyclase (CyaA; <xref ref-type="bibr" rid="bib58">Pastan and Perlman, 1970</xref>), increasing cyclic-AMP (cAMP) levels in cells (<xref ref-type="bibr" rid="bib12">Bettenbrock et al., 2007</xref>; <xref ref-type="bibr" rid="bib56">Park et al., 2006</xref>). The cAMP molecules, along with their receptor protein (Crp), activate genes related to the catabolism of secondary carbon sources, potentially supporting cellular functions and energy levels (<xref ref-type="bibr" rid="bib17">Deutscher, 2008</xref>; <xref ref-type="bibr" rid="bib18">Fic et al., 2009</xref>; <xref ref-type="bibr" rid="bib21">GÃ¶rke and StÃ¼lke, 2008</xref>; <xref ref-type="bibr" rid="bib34">Kolb et al., 1993</xref>). Here, using metabolomics, proteomics, and high-throughput screening of single-gene deletion strains, we have provided evidence that the Crp/cAMP regulatory complex maintains an active state of energy metabolism while downregulating anabolic pathways in the antibiotic-tolerant persister cells.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Disruption of the Crp/cAMP complex affects the formation of persister cells at the late stationary phase</title><p>Since Crp/cAMP-mediated metabolic changes can be induced by nutrient depletion during the stationary phase, we wanted to assess the effects of deleting the <italic>crp</italic> and <italic>cyaA</italic> genes (Î<italic>crp</italic> and Î<italic>cyaA</italic>) on both persister cell formation and metabolism during this phase. As anticipated, the deletion of the <italic>cyaA</italic> gene resulted in a notable reduction in intracellular cAMP concentration (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>). However, the Î<italic>crp</italic> strain exhibited an increase in cAMP concentration, potentially due to the negative feedback regulatory mechanism of the Crp/cAMP complex for the <italic>cyaA</italic> gene promoter (<xref ref-type="bibr" rid="bib31">Keseler et al., 2005</xref>; <xref ref-type="bibr" rid="bib41">Majerfeld et al., 1981</xref>; <xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>). When comparing the growth curves of <italic>E. coli</italic> wild-type (WT), Î<italic>crp</italic>, and Î<italic>cyaA</italic> main cultures under identical conditions studied here (see Materials and methods), all three strains started to enter the stationary phase around 5 hr, with the mutant strains exhibiting slightly lower optical density levels than the WT at this time point (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>). Also, our data provide evidence of an increase in cAMP levels in WT cells during their transition into the stationary phase (<xref ref-type="fig" rid="fig1s4">Figure 1âfigure supplement 4</xref>), aligning with existing literature (<xref ref-type="bibr" rid="bib12">Bettenbrock et al., 2007</xref>; <xref ref-type="bibr" rid="bib31">Keseler et al., 2005</xref>; <xref ref-type="bibr" rid="bib56">Park et al., 2006</xref>). For type I persister quantification, we diluted cells in the fresh medium, consistent with previous studies (<xref ref-type="bibr" rid="bib10">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>), at early (t=5 hr) and late (t=24 hr) stationary phases and subsequently exposed them to an extended period (20 hr) of ampicillin or ofloxacin treatment (200 Î¼g/mL ampicillin and 5 Î¼g/mL ofloxacin). These treatments were carried out at concentrations surpassing the minimum inhibitory concentrations (MIC), necessary for the selection of antibiotic-tolerant persister cells (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>; <xref ref-type="bibr" rid="bib29">Keren et al., 2004a</xref>). Also, type I persisters, formed during the stationary phase, exhibit a slow transition from a non-growing state to an active state when transferred to a fresh medium in the lag phase (<xref ref-type="bibr" rid="bib10">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="bib27">JÃµers and Tenson, 2016</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="bib72">Vulin et al., 2018</xref>); therefore, this transition requires longer antibiotic treatment durations. Moreover, we transferred an equal number of cells from each strain to the fresh medium to ensure consistency in cell numbers. To assess persistence, we collected samples during antibiotic treatment, washed them to remove antibiotics, and plated them on agar media to quantify colony-forming units (CFU) of surviving cells (see Materials and methods). The resulting biphasic kill curvesâplots of CFU levels over treatment timeâare characteristic of persistence phenotypes (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Notably, the WT strain showed a marked increase in both ampicillin- and ofloxacin-persister cells during the late stationary phase, in contrast to the mutant strains, where no such increase was observed (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). However, this trend was not observed in the early stationary phase (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). To confirm that the observed decrease in persister levels in the mutant strains in the late stationary phase is solely attributed to the perturbation of the Crp/cAMP regulatory network, we reintroduced <italic>crp</italic> expression to the Î<italic>crp</italic> strain using a low-copy plasmid carrying the <italic>crp</italic> gene and its promoter. As a control, we utilized an empty vector of the same plasmid. The results demonstrated that the expression of <italic>crp</italic> restored the persister level in the mutant strain, while the plasmid itself had no impact on persister levels (<xref ref-type="fig" rid="fig1s5">Figure 1âfigure supplement 5A, B</xref>). Altogether, these findings highlight the significant role of Crp/cAMP in ampicillin and ofloxacin persister formation in the late stationary phase.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Crp/cAMP regulation of persister cell formation in the stationary phase.</title><p><italic>E. coli</italic> K-12 MG1655 WT and mutant cells at early (t=5 hr) and late (t=24 hr) stationary phases were transferred to fresh medium with antibiotics for persister cell quantification. At time points 0, 2, 4, 6, 8, and 20 hr, 1 mL of the treated culture was washed with 1 X phosphate-buffered saline (PBS) to remove antibiotics. It was then serially diluted and plated on an agar plate to count the colony-forming units (CFUs). (<bold>A</bold>) Persister levels of ampicillin-treated culture with an antibiotic concentration of 200 Î¼g/mL. (<bold>B</bold>) Persister levels of ofloxacin-treated culture with an antibiotic concentration of 5 Î¼g/mL. (<bold>C</bold>) Persister levels of gentamicin-treated culture with an antibiotic concentration of 50 Î¼g/mL. The number of biological replicates is n=4 for all panels. Biphasic kill curves were generated using a non-linear model (see Materials and methods). Statistical significance tests were conducted using F-statistics (*pâ&lt;â0.05, **pâ&lt;â0.01, ****pâ&lt;â0.0001). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 1.</label><caption><title>cAMP concentrations normalized to cell numbers for <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic>.</title><p>The cAMP levels were measured in late stationary phase cultures at 450 nm using the Cyclic AMP XP Assay Kit (Cell Signaling Technology). n=4. Statistical significance was observed between control and mutant strains (*p&lt;0.05, ***p&lt;0.001, One-way ANOVA with Dunnettâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp1-v1.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 2.</label><caption><title>Genetic perturbation of Crp/cAMP enhanced P<italic><sub>cyaA</sub></italic> promoter activity, resulting in increased <italic>gfp</italic> expression.</title><p>Overnight cultures of <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains harboring the pMSs201 plasmid, which encodes green fluorescent protein (GFP) under the control of the P<italic><sub>cyaA</sub></italic> promoter, were diluted 1:1000 into fresh LB medium and incubated at 37 Â°C with shaking at 250 rpm for 24 hr. Cells at the late stationary phase were then collected, diluted in 1 X PBS, and analyzed by flow cytometry. n=4. Statistical significance was observed between control and mutant strains (****p&lt;0.0001, One-way ANOVA with Dunnettâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp2-v1.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 3.</label><caption><title>Growth curves of <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic>.</title><p>Optical densities of cell cultures at 600 nm (OD<sub>600</sub>) were measured every hour using a plate reader. n=3. The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp3-v1.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 4.</label><caption><title>Normalized cAMP concentrations of <italic>E. coli</italic> K-12 MG1655 WT.</title><p>The cAMP concentrations were measured in growth cultures at the indicated time points. First, the cAMP concentrations were normalized to the number of cells. Subsequently, the data were further normalized based on the time point 0 to mitigate errors associated with batch-to-batch assay kit variations and to capture the trend in cAMP levels across the time points. n=8. Statistical significance was observed between time points (**p&lt;0.01, One-way ANOVA with Dunnettâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard error.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp4-v1.tif"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 5.</label><caption><title>Persister levels of cells carrying the Crp expression system.</title><p>Cells at early (t=5 hr) and late (t=24 hr) stationary phases were transferred to fresh media with antibiotics for persister cell quantification. At time points 0, 2, 4, 6, 8, and 20 hr, 1 mL of the treated culture underwent two washes with 1 X PBS to remove antibiotics. It was then serially diluted and plated on an agar plate to count the CFUs. (<bold>A</bold>) Persister levels of ampicillin-treated culture (200 Î¼g/mL). (<bold>B</bold>) Persister levels of ofloxacin-treated cultures (5 Î¼g/mL). (<bold>C</bold>) Persister levels of gentamicin-treated culture (50 Î¼g/mL). n=4. Biphasic kill curves were generated using a non-linear model (see Materials and methods). Statistical significance tests were conducted using F-statistics (**pâ&lt;â0.01 and ****pâ&lt;â0.0001). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp5-v1.tif"/></fig><fig id="fig1s6" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 6.</label><caption><title>Persister levels of <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains at normalized antibiotic concentrations.</title><p>Panels show survival following treatment with (<bold>A</bold>) ampicillin, (<bold>B</bold>) ofloxacin, and (<bold>C</bold>) gentamicin. After treatment, samples were washed six times with 1 X PBS to minimize antibiotic carryover. Antibiotic concentrations were normalized to MICs to ensure valid comparisons across strains (The concentrations of 33ÃMIC for ampicillin and 100ÃMIC for ofloxacin and gentamicin match those used in <xref ref-type="fig" rid="fig1">Figure 1</xref>). n=4. Statistical significance was observed between control and mutant strains (****p&lt;0.0001, One-way ANOVA with Dunnettâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp6-v1.tif"/></fig><fig id="fig1s7" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 7.</label><caption><title>Agar plates showing <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains following treatment with antibiotics at normalized concentrations.</title><p>After treatment, cells were washed and subjected to 10-fold serial dilutions, then plated on agar. Plates were incubated for (<bold>A</bold>) 16 â¯hr, (<bold>B</bold>) 48 â¯hr, and (<bold>C</bold>) 72 â¯hr to assess colony formation over time. The panel is a representative biological replicate. Consistent results were seen across all three biological replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp7-v1.tif"/></fig><fig id="fig1s8" position="float" specific-use="child-fig"><label>Figure 1âfigure supplement 8.</label><caption><title>Deletion of <italic>crp</italic> and <italic>cyaA</italic> reduces ampicillin and ofloxacin persistence in the <italic>hipA7</italic> strain.</title><p>Persistence levels were assessed by exposing <italic>E. coli</italic> K-12 MG1655 WT, <italic>hipA7</italic>, <italic>hipA7Îcrp</italic>, and <italic>hipA7ÎcyaA</italic> strains in the late stationary phase to the specified antibiotics, followed by CFU quantification at designated time points. (<bold>A</bold>) Ampicillin (200 Âµg/ml), (<bold>B</bold>) Ofloxacin (5 Âµg/ml) and (<bold>C</bold>) Gentamicin (50 Âµg/ml). n=4. Statistical significance was observed between control and mutant strains (****p&lt;0.0001, One-way ANOVA with Dunnettâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig1-figsupp8-v1.tif"/></fig></fig-group><p>Ampicillin and ofloxacin, both broad-spectrum antibiotics with a strong dependence on cell metabolism (<xref ref-type="bibr" rid="bib84">Zheng et al., 2020</xref>), target cell wall synthesis and DNA gyrase activity, respectively. In addition to these two antibiotics, we also quantified AG-persister levels in both WT and mutant strains. This was achieved by exposing diluted cells from both early and late stationary phases to 50 Î¼g/mL gentamicin, a concentration exceeding the MIC levels (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). After prolonged gentamicin exposure (20 h), the tolerant cell colonies were found to be below the limit of detection for all strains and conditions (<xref ref-type="fig" rid="fig1">Figure 1C</xref>, <xref ref-type="fig" rid="fig1s5">Figure 1âfigure supplement 5C</xref>). Although bacterial tolerance can vary significantly depending on the specific antibiotics and growth phase used (<xref ref-type="bibr" rid="bib23">Hofsteenge et al., 2013</xref>), this outcome contrasts starkly with the observed levels of ampicillin and ofloxacin persisters in WT (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The mechanism by which AGs eliminate persister cells in the WT strain may be linked to their metabolism, given that AG uptake is an energy-requiring process (<xref ref-type="bibr" rid="bib4">Allison et al., 2011</xref>; <xref ref-type="bibr" rid="bib69">Taber et al., 1987</xref>), and their metabolism will be explored further in the subsequent section.</p><p>We would like to highlight that antibiotic concentrations, washing procedures (to remove antibiotics), and agar plate incubation times for CFU enumeration may affect experimental outcomes. However, variations in these parameters, including lower antibiotic concentrations normalized to the MIC of each strain (5Ãor 10ÃMIC; see <xref ref-type="fig" rid="fig1s6">Figure 1âfigure supplement 6</xref>), additional washing steps to ensure complete removal of antibiotics (see <xref ref-type="fig" rid="fig1s6">Figure 1âfigure supplement 6</xref>), and extended agar plate incubation times of up to 48 hours (see <xref ref-type="fig" rid="fig1s7">Figure 1âfigure supplement 7</xref>), did not affect the persistence phenotype. The Î<italic>crp</italic> and Î<italic>cyaA</italic> strains consistently showed reduced ampicillin and ofloxacin persistence compared to WT, whereas all three strains showed no detectable persisters following gentamicin treatment (<xref ref-type="fig" rid="fig1s6">Figure 1âfigure supplements 6</xref> and <xref ref-type="fig" rid="fig1s7">7</xref>). Moreover, we examined the impact of Crp/cAMP disruption in the HipA7 strain to assess whether the role of Crp/cAMP in persistence extends to a genetically sensitized, persister-enriched background. Deletion of either <italic>crp</italic> or <italic>cyaA</italic> in the HipA7 background significantly reduced persistence to both ampicillin and ofloxacin during the late stationary phase (<xref ref-type="fig" rid="fig1s8">Figure 1âfigure supplement 8</xref>), mirroring the effects observed in the WT strain. Altogether, these results show that disruption of the Crp/cAMP regulatory network impairs persister formation during the late stationary phase, underscoring its critical role in ampicillin and ofloxacin tolerance.</p></sec><sec id="s2-2"><title>Crp/cAMP complex governs <italic>E. coli</italic> stationary phase metabolism</title><p>To determine whether the reduced ampicillin and ofloxacin persister levels at the late stationary phase in the mutant strains (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>) are linked to stationary phase metabolism, we utilized untargeted mass spectrometry (MS). This approach facilitated the quantification of metabolites in Î<italic>crp</italic> cells, allowing for a comparison with WT controls in both the early and late stationary phases (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Since both Î<italic>crp</italic> and Î<italic>cyaA</italic> strains exhibit the same persistence phenotype, and <italic>crp</italic> deletion effectively abolishes Crp/cAMP complex function, we used the Î<italic>crp</italic> mutant for metabolomic profiling to capture key regulatory changes while maintaining experimental feasibility. The metabolomics data were subjected to unsupervised hierarchical clustering, and metabolites identified in independent biological replicates of each strain and condition were found to cluster together (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), thus confirming the reproducibility of our data.</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>The effect of Crp/cAMP on persister cell metabolism during stationary phase.</title><p>(<bold>A</bold>) MS analysis of <italic>E. coli</italic> K-12 MG1655 WT, and Î<italic>crp</italic> at early (t=5 hr) and late (t=24 hr) stationary phases. Unsupervised hierarchical clustering was applied to standardized metabolic data. Each column represents a biological replicate. n=4. (<bold>B</bold>) Pathway enrichment analysis was conducted using MetaboAnalyst (<xref ref-type="bibr" rid="bib38">Lu et al., 2023</xref>). Upregulated and downregulated pathways of the Î<italic>crp</italic> strain compared to WT in the late stationary growth phase were provided in this figure. (<bold>C, D</bold>) Pathway enrichment maps comparing metabolites of the TCA cycle, pentose phosphate metabolism, glycolysis, gluconeogenesis, and pyruvate metabolism in Î<italic>crp</italic> versus WT for early and late stationary phase conditions, respectively. Circle size corresponds to the ratio of normalized metabolite intensities between mutant and control cells. Blue (pââ¤â0.05 for dark blue; 0.05â&lt;âp â&lt;â 0.10 for light blue) and red (pââ¤â0.05 for dark red; 0.05â&lt;âp â&lt;â 0.10 for light red) indicate significantly downregulated or upregulated metabolites in the mutant compared to the control. White signifies no significant difference. n=4 for all panels. ESP: Early stationary phase, LSP: Late stationary phase.</p><p><supplementary-material id="fig2sdata1"><label>Figure 2âsource data 1.</label><caption><title>Normalized metabolomics data of early and late stationary phases of wild-type and mutant <italic>crp</italic> across three biological replicates.</title><p>Data collected and analyzed by Metabolon Inc (Morrisville, NC).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-99735-fig2-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 1.</label><caption><title>The pathway enrichment analysis comparing WT and Î<italic>crp</italic> strains during the early stationary phase cultures.</title><p>The analysis was conducted using MetaboAnalyst, with a threshold ratio (Î<italic>crp</italic>/WT) set at â¤0.5 for downregulation and â¥2 for upregulation. (<bold>A</bold>) Upregulated and (<bold>B</bold>) Downregulated pathways in the Î<italic>crp</italic> strain compared to WT during the early stationary growth phase (ESP).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig2-figsupp1-v1.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 2.</label><caption><title>The pathway enrichment analysis for the WT strain.</title><p>The analysis was conducted using MetaboAnalyst, with a threshold ratio (LSP/ESP) set at â¤0.5 for downregulation and â¥2 for upregulation. (<bold>A</bold>) Upregulated and (<bold>B</bold>) Downregulated pathways of the WT strain in the late stationary growth phase (LSP) compared to the WT strain in the early stationary phase (ESP).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig2-figsupp2-v1.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2âfigure supplement 3.</label><caption><title>The pathway enrichment analysis for the Î<italic>crp</italic> strain.</title><p>The analysis was conducted using MetaboAnalyst, with a threshold ratio (LSP/ESP) set at â¤0.5 for downregulation and â¥2 for upregulation. (<bold>A</bold>) Upregulated and (<bold>B</bold>) Downregulated pathways of the Î<italic>crp</italic> strain in the late stationary growth phase (LSP) compared to the Î<italic>crp</italic> strain in the early stationary phase (ESP).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig2-figsupp3-v1.tif"/></fig></fig-group><p>To elucidate the upregulated and downregulated metabolic pathways in the mutant strain as compared to the WT strain, we performed enrichment analyses utilizing MetaboAnalyst (<xref ref-type="bibr" rid="bib38">Lu et al., 2023</xref>). For downregulated pathways, we considered a threshold ratio of 0.5 or lower, where the ratio indicates metabolite levels in the mutant strain relative to the WT (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2A</xref>). Conversely, for upregulated pathways, the threshold ratio was set at 2 or higher (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2B</xref>). The enrichment ratio for each pathway was calculated based on the number of metabolite hits compared to the expected hits derived from the chemical structure library (<xref ref-type="bibr" rid="bib38">Lu et al., 2023</xref>). Our extensive comparison of the mutant cells to the WT cells through pathway enrichment analysis (refer to <xref ref-type="fig" rid="fig2">Figure 2B</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplements 1</xref>â<xref ref-type="fig" rid="fig2s3">3</xref> for pairwise comparison of different conditions) revealed several important findings:</p><list list-type="order" id="list1"><list-item><p>During the early stationary phase, we observe a slight downregulation in the abundance of TCA cycle metabolites, including citrate and fumarate, in the Î<italic>crp</italic> strain compared to WT (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s1">Figure 2âfigure supplement 1</xref>). However, as the late stationary phase progresses, the downregulation in both TCA cycle and pentose phosphate metabolism becomes more pronounced in the Î<italic>crp</italic> strain (<xref ref-type="fig" rid="fig2">Figure 2B and D</xref>).</p></list-item><list-item><p>The Î<italic>crp</italic> strain exhibits upregulation of several metabolites compared to WT during both early and late stationary phases, primarily associated with anabolic pathways. Particularly, the upregulation of some of these pathways becomes more pronounced during the late stationary phase. These pathways include crucial metabolites like deoxyribonucleosides and ribonucleosides (which play essential roles in DNA and RNA synthesis), fatty acids and carboxylic acids (the main components of bacterial cell membranes), and peptides (which are linked to protein synthesis) (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p></list-item><list-item><p>During the early stationary phase, we noticed a significant upregulation in the abundance of intermediate metabolites related to glycolysis, gluconeogenesis, and pyruvate metabolism in mutant cells compared to WT cells (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). This observation is not surprising, as the inhibition of the TCA cycle in the mutant strain could potentially redirect metabolic fluxes toward glycolysis and lactate metabolism.</p></list-item></list><p>Altogether, our metabolic data indicate that, in the stationary phase, WT cells maintain their energy metabolism to some extent while downregulating their anabolic pathways (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This metabolic state appears to be regulated by the Crp/cAMP complex, as perturbing its function leads to a significant downregulation of energy metabolism and an upregulation in the abundance of anabolic metabolites (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p></sec><sec id="s2-3"><title>Proteomics analysis revealed upregulated pathways in the Î<italic>crp</italic> strain associated with anabolic metabolism, alongside the downregulation of key proteins in energy metabolism</title><p>Since the Crp/cAMP complex acts as a transcriptional regulator affecting the expression of metabolic proteins whose abundance directly affects cellular metabolites, we performed untargeted proteomics, our second genomic-level study, to further validate our results. Considering the noticeable metabolic alterations observed during the late stationary phase, we utilized MS to quantify proteins in Î<italic>crp</italic> cells and compared them to WT controls at this stage. The resulting proteomics data were subjected to unsupervised hierarchical clustering, and the proteins identified in independent biological replicates of each strain were found to cluster together, confirming the consistency of our findings (<xref ref-type="fig" rid="fig3s1">Figure 3âfigure supplement 1</xref>). By analyzing protein-protein association networks and employing functional enrichment through STRING (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>), which integrates various functional pathway classification frameworks such as Gene Ontology annotations, KEGG pathways, and UniProt keywords, we pinpointed various upregulated and downregulated pathways in the mutant strain when compared to the WT (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). The upregulated pathways are associated with anabolic metabolism and encompass peptidoglycan metabolic processes, cell wall organization or biogenesis, cellular component organization or biogenesis, regulation of cell shape, cell cycle, and cell division (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Also, the mutant strain displayed downregulated pathways, encompassing glycerol metabolism, TCA cycle, pyruvate metabolism, glycolysis, and various pathways associated with ribosome and transcriptional factor activity (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Our analysis specifically pinpointed a cluster of proteins involved in energy metabolism and respiratory processes. Notably, this cluster includes GltA, SdhB, SucC, SucD, FrdB, FrdA, AcnA, AceA, and Mdh proteins, which play crucial roles in either the TCA cycle or as membrane-bound components of ETC (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Altogether, the alignment between metabolomics and proteomics analyses provides additional validation for the Crp/cAMP-mediated metabolic state.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Validation of Crp/cAMP-mediated metabolic state in persister cells through proteomics analysis.</title><p>Pathway enrichment analysis was conducted in STRING (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>) for upregulated (<bold>A</bold>) and downregulated (<bold>B</bold>) proteins. Genes highlighted in red are linked with the upregulated protein networks, while genes in blue, gray, and purple correspond to those in the downregulated protein network. The visual network in STRING illustrates protein interactions. In evidence mode, color in the network represents the interaction evidence of data support, derived from curated databases, experimental data, gene neighborhood, gene fusions, co-occurrence, co-expression, protein homology, and text mining (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>).</p><p><supplementary-material id="fig3sdata1"><label>Figure 3âsource data 1.</label><caption><title>Normalized proteomics data of the late stationary phase of wild-type and mutant <italic>crp</italic> across three biological replicates.</title><p>Data collected by UT Healthâs Clinical and Translational Proteomics Service Center (Houston, TX).</p></caption><media mimetype="application" mime-subtype="xlsx" xlink:href="elife-99735-fig3-data1-v1.xlsx"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3âfigure supplement 1.</label><caption><title>The MS analysis of proteins from both WT and Î<italic>crp</italic> strains at the late stationary phase.</title><p>The proteomic data were subjected to unsupervised hierarchical clustering. Each column in the figure represents a biological replica. n=3.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig3-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-4"><title>Crp/cAMP complex shapes <italic>E. coli</italic> cell proliferation dynamics</title><p>The omics data suggest that the upregulation in the abundance of anabolic metabolites and proteins, particularly those related to cell wall organization or biogenesis, cell cycle, and cell division, in the stationary-phase mutant cells, would likely enhance their ability to resume growth upon transitioning to fresh medium. To investigate this, we utilized a cell proliferation assay that employed an inducible fluorescent protein (mCherry) expression cassette. This assay provided us with the ability to monitor non-growing cells at a single-cell resolution, as described previously (<xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>; <xref ref-type="bibr" rid="bib62">Roostalu et al., 2008</xref>). The mCherry expression cassette is controlled by an isopropyl Ã-D-1-thiogalactopyranoside (IPTG) inducible synthetic T5 promoter that was previously inserted into the chromosome of an <italic>E. coli</italic> strain carrying a <italic>lacI<sup>q</sup></italic> promoter mutation (<xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>). This configuration allowed for precise regulation of mCherry expression using IPTG. Here, we introduced <italic>crp</italic> and <italic>cyaA</italic> deletions into this strain. These deletions reduced the persistence of the mCherry-expressing <italic>E. coli</italic> strain in the late stationary phase (<xref ref-type="fig" rid="fig4s1">Figure 4âfigure supplement 1</xref>), consistent with the findings presented in <xref ref-type="fig" rid="fig1">Figure 1</xref>. To perform the growth assay, we induced mCherry expression in the main cultures and then washed the cells to remove IPTG. The cells were then inoculated into a fresh medium without IPTG, and their growth was analyzed with a flow cytometer. This allowed us to track the dilution of mCherry protein within the cells, which served as an indicator of cell proliferation. As shown in <xref ref-type="fig" rid="fig4">Figure 4A</xref>, initially, all cells exhibited high red fluorescence. However, as cells underwent division, the red fluorescence of the overall population decreased in the absence of the inducer (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Notably, within the WT strain, a subpopulation from the late stationary phase cultures displayed constant fluorescence levels, indicating their inability to divide (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). In contrast to the WT strain, we did not detect similar subpopulations in the mutant strains (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Additionally, this subpopulation of non-growing cells does not emerge during the early stationary phase cultures (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). This observation provides an explanation for the observed reduction in persister levels in these mutant strains in the late stationary phase, as the enrichment of persister cells within these non-growing cell subpopulations was reported in previous studies (<xref ref-type="bibr" rid="bib26">JÃµers et al., 2010</xref>; <xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>; <xref ref-type="bibr" rid="bib62">Roostalu et al., 2008</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>The role of Crp/cAMP in non-growing cell formation.</title><p>(<bold>A, B</bold>) Flow cytometry histograms depict mCherry expression in <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> at early (t=5 hr) and late (t=24 hr) stationary phases, respectively. Cells containing an IPTG-inducible mCherry expression system were cultivated with IPTG. After washing and dilution of early and late stationary phase cells in IPTG-free fresh media, fluorescence was tracked in non-growing and growing cells for 2.5 hr. The panel is a representative biological replicate. Consistent results were seen across all three biological replicates. (<bold>C</bold>) Growth curves of WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> cultures were determined using flow cytometry to calculate lag and doubling times. Lag times were calculated using the âMicrobial lag phase duration calculatorâ (<xref ref-type="bibr" rid="bib51">Opalek et al., 2022</xref>). Doubling times were computed using the formula t<sub>d</sub>=Ît/(3.3xLog<sub>10</sub>(N/N<sub>o</sub>)). n=3. *Statistical significance observed between control and mutant strains (p&lt;0.05, two-tailed t-test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 1.</label><caption><title>Persister levels of <italic>E. coli</italic> WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> cells with the integrated mCherry expression system.</title><p>Late stationary phase cultures (t=24 hr) were transferred to fresh media and treated with ampicillin (200 Î¼g/mL), ofloxacin (5 Î¼g/mL), and gentamicin (50 Î¼g/mL) for 20 hr. Subsequently, 1 mL of the treated culture underwent two washes with 1 X PBS to remove antibiotics. It was then serially diluted and plated on an agar plate to count the CFUs. The levels of ofloxacin and gentamicin persisters in the mutant strains were below the limit of detection. n=4. Statistical significance was observed between control and mutant strains (***p&lt;0.001, ****p&lt;0.0001, Two-way ANOVA with Tukeyâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig4-figsupp1-v1.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4âfigure supplement 2.</label><caption><title>Non-growing cell levels in the <italic>E. coli</italic> strain carrying the Crp expression system.</title><p>(<bold>A, B</bold>) Flow cytometry histograms depict mCherry expression in Î<italic>crp</italic> +pUA66 <italic>crp</italic>, and Î<italic>crp</italic> +pUA66 EV at early (t=5 hr) and late (t=24 hr) stationary phases, respectively. Cells containing an IPTG-inducible mCherry expression system were cultivated with IPTG. After washing and dilution of early and late stationary phase cells in IPTG-free fresh media, fluorescence was tracked in non-growing and growing cells for 2.5 hr. The panel is a representative biological replicate. Consistent results were seen across all three biological replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig4-figsupp2-v1.tif"/></fig></fig-group><p>To confirm the significance of Crp/cAMP in the formation of non-growing cells, we introduced the expression plasmid carrying the <italic>crp</italic> gene into the Î<italic>crp</italic> strain. As anticipated, the introduction of the <italic>crp</italic> expression plasmid resulted in the emergence of a non-growing population within the culture, contrasting with the mutant strain containing the empty plasmid vector used as a control (<xref ref-type="fig" rid="fig4s2">Figure 4âfigure supplement 2A, B</xref>). The reduced capacity of stationary-phase WT cells to initiate proliferation upon transfer to a fresh medium suggests the possible presence of an extended lag phase in these cells. To investigate this, we employed flow cytometry to precisely quantify cell numbers and generate growth curves for both WT and mutant strains. As anticipated, the growth curve of the WT strain displayed a slower initial growth rate and a prolonged lag phase duration compared to the mutant strains (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Conversely, the mutant strains displayed a shorter lag phase, yet they demonstrated an increased doubling time in the exponential phase compared to WT (<xref ref-type="fig" rid="fig4">Figure 4C</xref>), which was also anticipated, considering their decreased reliance on oxidative phosphorylation due to TCA cycle inhibition. Altogether, these results provide additional support and validation for the findings from our metabolomics and proteomics data, as our data reveals a correlation between the abundance of molecules associated with cell division and the ability of the stationary phase cells to resume growth.</p></sec><sec id="s2-5"><title>Persister cells rely on energy metabolism</title><p>The Crp/cAMP-mediated metabolic state, characterized by increased respiration in WT compared to mutant strains, was further validated using redox sensor green (RSG) dye and a reporter plasmid measuring the promoter activity of succinate:quinone oxidoreductase (SQR) genes. The SQR reporter system (<xref ref-type="bibr" rid="bib81">Zaslaver et al., 2006</xref>) employs green fluorescent protein (GFP) expression, regulated by the promoter of the SQR operon, which includes the <italic>sdhA</italic>, <italic>sdhB</italic>, <italic>sdhC</italic>, and <italic>sdhD</italic> subunit genes. The SQR complex plays a vital role in cellular metabolism by catalyzing the oxidation of succinate to fumarate concurrently with the reduction of ubiquinone to ubiquinol, thus directly linking the TCA cycle with the respiratory ETC (<xref ref-type="bibr" rid="bib31">Keseler et al., 2005</xref>). Our results indicate an upregulation of the SQR promoter activity in WT cells compared to the mutant strains in the stationary phase, validating the findings from our metabolomics and proteomics data (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). The RSG dye, on the other hand, serves as a well-established metabolic indicator, measuring bacterial oxidation-reduction activity, a crucial function involving the ETC driven by the TCA cycle. Once reduced by bacterial reductases, the RSG dye emits a stable green fluorescent signal (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>). Our data demonstrate that the redox activities of WT cells are much higher and more heterogeneous compared to those of the mutant strains in the late stationary phase, further corroborating the results from our preceding analyses (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Furthermore, we utilized a methodology that integrates the mCherry expression system, flow cytometry, and ampicillin-mediated cell lysis to determine whether persister cells in WT still maintain their respiration. In this assay, both the WT and mutant strains carrying the mCherry expression system were exposed to ampicillin after transferring them to a fresh medium. The inducer was added to both growth and treatment cultures to sustain the cells' red signals. Unlike other antibiotics, ampicillin disrupts cell wall synthesis, leading to the lysis of cells upon their resumption of growth. As seen in <xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>, the cells that were lysed lost their mCherry signals. On the other hand, the resilient, tolerant cells that evaded ampicillin-induced lysis maintained their mCherry levels throughout the treatment. In the mutant strains, ampicillin was effective in lysing almost all cells as anticipated, leaving no or a small number of intact cells (<xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>). However, in the WT strain, we detected a subpopulation of intact cells throughout the entire treatment period (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, <xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>). While the population-level redox activities of these tolerant intact cells in WT are lower than those of exponential phase cells, they still displayed a significant increase in RSG levels compared to cell populations before antibiotic treatments or untreated control cells subjected to identical conditions (<xref ref-type="fig" rid="fig5">Figure 5D</xref>)<bold>,</bold> suggesting that they maintain steady-state energy metabolism. We want to highlight that not all intact cells in the WT strain reported here are persisters. A significant portion comprises 'viable but non-culturable' (VBNC) cells, and WT cells exhibit markedly higher VBNC levels than Î<italic>crp</italic> and Î<italic>cyaA</italic> strains (<xref ref-type="fig" rid="fig5s3">Figure 5âfigure supplement 3</xref>). VBNC cells can be quantified from intact cells following beta-lactam treatments (<xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>; <xref ref-type="bibr" rid="bib62">Roostalu et al., 2008</xref>). These cells may exhibit metabolic activities but are unable to readily colonize upon transfer to fresh medium (<xref ref-type="bibr" rid="bib8">Ayrapetyan et al., 2018</xref>; <xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>). Collectively, our metabolic measurement data (<xref ref-type="fig" rid="fig5">Figure 5AâC</xref>) aligns with the findings from our omics analyses, and the number of intact cells observed in WT after beta-lactam treatment is consistent with the count of non-growing cells in WT (<xref ref-type="fig" rid="fig4">Figure 4B</xref> vs <xref ref-type="fig" rid="fig5s2">Figure 5âfigure supplement 2</xref>). These non-growing cells are anticipated to be less susceptible to lysis by beta-lactams (<xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>; <xref ref-type="bibr" rid="bib62">Roostalu et al., 2008</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Crp/cAMP-mediated metabolic state of persister cells.</title><p>(<bold>A</bold>) GFP reporter plasmid introduced into <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> cells to monitor SQR gene activity. Flow cytometry was used to detect activity at early (t=5 hr) and late (t=24 hr) stationary phases. The panel on the left represents a biological replicate, and the results are consistent across all three replicates, as demonstrated in the panel on the right. Statistical significance observed between control and mutant groups (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, two-tailed t-test). (<bold>B</bold>) Redox activities of <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> cells were measured at early (t=5 hr) and late (t=24 hr) stationary phases by flow cytometry using a RSG dye. This dye fluoresces green after reduction by bacterial reductases. A representative biological replicate is shown (left), with consistent results across all five replicates (right). Statistical significance observed between control and mutant groups (*p&lt;0.05, **p&lt;0.01, two-tailed t-test). (<bold>C</bold>) <italic>E. coli</italic> cells with integrated mCherry expression system used to validate cellular respiration. Cells were diluted into fresh media and treated with ampicillin (200 Î¼g/mL) for 20 hr. Flow cytometry measured the red fluorescence of intact surviving cells. A representative biological replicate is shown, with consistent results across all three replicates. (<bold>D</bold>) RSG levels of cells (carrying the mCherry expression system) at exponential phase (t=3 hr); cells before ampicillin treatment; non-lysed (intact) cells after 20 hr of ampicillin treatment; and untreated cells after 20 hr of culturing. A representative biological replicate is shown (left), with consistent results across all four replicates (right). Statistical significance observed between intact antibiotic-treated cells and others (*p&lt;0.05, **p&lt;0.01, two-tailed t-test). (<bold>E</bold>) High-throughput screening of mutants from the Keio collection. The mutant strains selected are associated with central metabolism. Stationary phase cells were diluted 100-fold in fresh medium and treated with ampicillin (200 Î¼g/mL) or ofloxacin (5 Î¼g/mL) for 20 hr. Treated cultures were washed, serially diluted, and plated on agar plates to quantify CFUs. (<bold>F</bold>) Genes related to the TCA cycle, ETC, ATP synthase, glycolysis, and pentose phosphate pathway (PPP) were knocked out and then treated with ampicillin (200 Î¼g/mL) or ofloxacin (5 Î¼g/mL) to enumerate CFUs. n=4. Biphasic kill curves were generated using a non-linear model. Statistical significance tests were conducted using F-statistics (*pâ&lt;â0.05, and **pâ&lt;â0.01). Each data point represents the mean value âÂ± standard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 1.</label><caption><title>RSG staining control for bacterial metabolic activities.</title><p>Exponential phase (t=3 hr) cells were stained with 1 Î¼M RSG for 10 min at 37 Â°C before analyzing by flow cytometry. Unstained cells and cells treated with 20 Î¼M CCCP +1 Î¼M RSG were used as control. CCCP was expected to reduce cellular redox activities. The panel is a representative biological replicate. Consistent results were seen across all three biological replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 2.</label><caption><title>Intact (non-lysed) cell levels of <italic>E. coli</italic> WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> cells with the integrated mCherry expression system.</title><p>mCherry-positive cells were diluted into fresh media and treated with ampicillin (200 Î¼g/mL) for 20 hr. Flow cytometry was used to measure the red fluorescence of intact surviving cells at time points t=0, 1, 2, 4, 6, and 20 hr. A representative biological replicate is shown, with consistent results across all three replicates.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig5-figsupp2-v1.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 3.</label><caption><title>VBNC levels of <italic>E. coli</italic> WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> cells with the integrated mCherry expression system.</title><p>Flow cytometry was employed to quantify intact surviving cells. Persister cells were quantified by plating the cells on agar media. Viable but nonculturable (VBNC) cells were enumerated by subtracting persister levels from the intact cell levels. n=4. Statistical significance was observed between control and mutant strains (****p&lt;0.0001, One-way ANOVA using Dunnettâs multiple comparisons test). The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig5-figsupp3-v1.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5âfigure supplement 4.</label><caption><title>Cell counts of <italic>E. coli</italic> K-12 MG1655 WT and mutant strains using flow cytometry at late stationary phase.</title><p>Cells were diluted 100-fold into 1 mL of 1 X PBS. n=4. The data for each time point represent the mean value âÂ±âstandard deviation.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-fig5-figsupp4-v1.tif"/></fig></fig-group></sec><sec id="s2-6"><title>The genomic-level screening of <italic>E. coli</italic> knockout underscores the significance of energy metabolism in sustaining the viability of persister cells</title><p>Although some metabolic genes, including those encoding the TCA cycle (e.g. <italic>sdhA, sucB, mdh, icd</italic>), have been studied in <italic>E. coli</italic> (<xref ref-type="bibr" rid="bib39">Luidalepp et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Ma et al., 2010</xref>; <xref ref-type="bibr" rid="bib42">Manuse et al., 2021</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="bib78">Yu et al., 2019</xref>), a comprehensive genomic-level screening strategy is necessary to validate which metabolic pathways are truly associated with antibiotic tolerance. To further underscore the importance of energy metabolism, we conducted a high-throughput screening of 149 different <italic>E. coli</italic> K-12 BW25113 mutant strains from the Keio knockout library (<xref ref-type="bibr" rid="bib9">Baba et al., 2006</xref>). The selected strains are related to central carbon metabolism, encompassing glycolysis, pentose phosphate pathways, TCA cycle, ETC, ATP synthase, and fermentation pathways (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). While the deletion of genes related to glycolysis and pentose phosphate pathways did not affect antibiotic tolerance in the cells, some mutant strains associated with cytochrome bo and quinone oxidoreductase complexes (e.g. <italic>cyo</italic> genes and <italic>nuoL</italic>) exhibited enhanced tolerance (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). However, the mutant strains exhibited reduced tolerance to both antibiotics compared to the control <italic>E. coli</italic> K-12 BW25113 WT strain, which was found to be largely associated with the TCA pathway (<italic>sucA, sucB, lpd, sucC, sucD, sdhA, sdhB, sdhC, sdhD, gltA, acnB, aceE, fumA, mdh</italic> and <italic>fumC</italic>), ETC (<italic>nuoB, nuoC, nuoI, nuoK, nuoM,</italic> and <italic>narV</italic>), ATP synthesis (<italic>atpA, atpB, atpC, atpD, atpE,</italic> and <italic>atpH</italic>), and mixed acid fermentation pathways (<italic>ldhA, fdhF, pta, adhE,</italic> and <italic>frdC</italic>) (<xref ref-type="fig" rid="fig5">Figure 5E</xref>, <xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>). We acknowledge that the Keio strains were generated in a high-throughput manner, and there might be unknown errors in their genomic DNA. To ensure the reproducibility of our findings, we generated knockout strains for key genes associated with the TCA, ETC, ATP synthase, glycolysis, and pentose phosphate pathway (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, see <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref> for detailed description of genes). We then tested their antibiotic tolerance, and our results were consistent with the omics data and screening outcomes (<xref ref-type="fig" rid="fig5">Figure 5F</xref>), confirming the critical role of energy metabolism, specifically the TCA cycle, ETC, and ATP synthase, in bacterial persistence. We note that equal numbers of cells from each strain were transferred into antibiotic treatment media to ensure consistency in cell numbers, and no significant growth deficiencies or differences in cell density were observed in the late stationary phase of the knockout strains (<xref ref-type="fig" rid="fig5s4">Figure 5âfigure supplement 4</xref>).</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Our study highlights the crucial role of the Crp/cAMP complex in maintaining the metabolic state of stationary-phase persister cells, enabling their survival under adverse conditions. Through metabolomics, proteomics, and high-throughput screening of single-gene deletion strains, we substantiated that the Crp/cAMP regulatory complex sustains an active respiratory state while downregulating anabolic pathways in persister cells. This respiratory state is vital for the survival of persister cells, as perturbing the Crp/cAMP complex or respiration significantly reduced persister phenotypes, which may explain the previously reported decrease in antibiotic tolerance in <italic>E. coli</italic> cells cultured under anaerobic conditions (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). Notably, we observed an upregulation of anabolic metabolites and proteins when the Crp/cAMP regulatory complex was perturbed, particularly those associated with cell wall organization, cell cycle, and cell division, enhancing the ability of stationary-phase mutant cells to resume growth. Although the literature has shown associations between antibiotic tolerance with proteins involved in cell division and the TCA cycle (e.g. SdhA, SucB, Mdh) (<xref ref-type="bibr" rid="bib39">Luidalepp et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Ma et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="bib78">Yu et al., 2019</xref>), our study establishes a strong link between these critical cellular processes and the Crp/cAMP complex, providing much-needed clarity in the field. In fact, upon investigating Crp/cAMP regulons via the Ecocyc database (<xref ref-type="bibr" rid="bib31">Keseler et al., 2005</xref>), we identified that certain metabolic genes, deleted in our <italic>E. coli</italic> K-12 MG1655 background, are potentially regulated by Crp/cAMP (<xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>), providing additional support for the validity of our omics results.</p><p>We acknowledge that our metabolomic and proteomic data were obtained at the whole-population level, rather than from isolated persister cells. Fluorescent reporters combined with fluorescence-activated cell sorting (FACS) have been utilized to study persister cells, including in our previous studies (<xref ref-type="bibr" rid="bib5">Amato et al., 2013</xref>; <xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). However, this approach only enriches for persisters rather than isolating a pure population, as persisters still constitute a small fraction of the sorted cells. Despite these limitations, our population-level analyses provide valuable insights into the role of the Crp/cAMP complex in regulating non-growing cell formation and persistence (<xref ref-type="fig" rid="fig4">Figure 4</xref>). We further validated these findings through single-gene deletions and flow cytometry-based assays (<xref ref-type="fig" rid="fig5">Figure 5</xref>), confirming a consistent reduction in both non-growing and persister cells in Crp/cAMP-deficient strains.</p><p>The deletion of <italic>cyaA</italic> resulted in a reduction of cAMP levels, as expected given the role of the CyaA enzyme in cAMP synthesis (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>). Conversely, the removal of <italic>crp</italic> led to an increase in cAMP levels compared to those in wild-type cells. Notably, this increase is statistically significant (<xref ref-type="fig" rid="fig1s1">Figure 1âfigure supplement 1</xref>). Although this is an interesting observation, it is likely due to the feedback regulation of the Crp/cAMP complex on <italic>cyaA</italic> expression (<xref ref-type="bibr" rid="bib3">Aiba, 1985</xref>; <xref ref-type="bibr" rid="bib32">Keseler et al., 2011</xref>; <xref ref-type="bibr" rid="bib41">Majerfeld et al., 1981</xref>). Specifically, disruption of Crp function is expected to derepress the <italic>cyaA</italic> promoter (P<italic><sub>cyaA</sub></italic>), leading to increased CyaA expression and elevated cAMP levels. To test this, we employed a P<italic><sub>cyaA</sub>-gfp</italic> reporter plasmid (pMSs201) in <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains to monitor promoter activity. As anticipated, deletion of <italic>crp</italic> led to enhanced <italic>gfp</italic> expression, confirming that Crp/cAMP negatively regulates <italic>cyaA</italic> expression via feedback. These results clarify the observed cAMP differences and support the regulatory role of the Crp/cAMP complex (<xref ref-type="fig" rid="fig1s2">Figure 1âfigure supplement 2</xref>).</p><p>Our findings reveal substantial heterogeneity in metabolism (measured by RSG) among WT stationary phase cells, contrasting with the more uniform behavior observed in Î<italic>crp</italic> and Î<italic>cyaA</italic> strains (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). We also demonstrated the presence of two distinct populations in WT cells during the late stationary phase: one that resumes rapid growth and another subpopulation that does not resume growth when transferred to a fresh medium (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The absence of this non-growing cell subpopulation in the mutant strains could account for their sensitivity to AGs. However, the mechanism by which AGs kill these non-growing cells in the WT strain remains perplexing. The underlying reasons might be linked to their metabolism, as AG uptake is an energy-requiring process, relying on the electron flow through membrane-bound respiratory chains (<xref ref-type="bibr" rid="bib4">Allison et al., 2011</xref>). Moreover, persister cells obtained from various antibiotics, such as ampicillin and ofloxacin, in WT <italic>E. coli</italic> were previously found to exhibit sensitivity to AGs when sugar molecules were introduced into the cultures (<xref ref-type="bibr" rid="bib4">Allison et al., 2011</xref>; <xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>). However, the enhanced sensitivity mediated by sugar molecules was reversed to its original state in a subsequent study when the Crp/cAMP complex was genetically perturbed (<xref ref-type="bibr" rid="bib47">Mok et al., 2015a</xref>). This can be attributed to the lack of active energy metabolism in these genetically altered strains, as suggested by our comprehensive genomic-level analyses here. While the absence of cell division in non-growing cell subpopulations in WT may suggest a downregulation in anabolic metabolism, their energy metabolism may remain partially active, which could potentially explain the phenomenon of AG potentiation. Indeed, our results presented in <xref ref-type="fig" rid="fig5">Figure 5D</xref> support this interpretation.</p><p>Antibiotics are generally effective against proliferating bacteria, leading to the notions that tolerance is linked to temporary growth suppression and that persister cells are dormant phenotypes with repressed metabolism. Although persister cells are generally considered to have reduced metabolic activity compared to exponentially growing cells, their survival may still depend on energy metabolism. Also, the direct comparison of persister cell metabolism to that of exponentially growing cells may not be the best approach. Growing cells have a very high energy output and consume metabolites at a fast pace. Therefore, any comparison between tolerant and non-tolerant cell populations requires proper normalization techniques such as adjusting cellular metabolic activities to the amount of substrate utilized by cells. An example of this normalization was conducted by Heinemannâs group (<xref ref-type="bibr" rid="bib61">Radzikowski et al., 2016</xref>), demonstrating that ATP production rates per substrate in tolerant cells exceed those of exponentially growing cells.</p><p>We diluted cells in fresh medium at early and late stationary phases before antibiotic treatments. This step is essential for quantifying type I persisters, as these cells do not readily resume growth upon dilution in the fresh medium during the lag phase (<xref ref-type="bibr" rid="bib10">Balaban et al., 2004</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). We acknowledge that antibiotic tolerance is influenced by various factors, including culture dilutions, media, specific strains, antibiotics tested, treatment durations, and the growth phase during treatment administration. These factors may contribute to variations in reported persister levels observed in the Î<italic>cyaA</italic> strain during the exponential phase (<xref ref-type="bibr" rid="bib13">Chu et al., 2012</xref>; <xref ref-type="bibr" rid="bib49">Molina-Quiroz et al., 2018</xref>; <xref ref-type="bibr" rid="bib57">Parsons et al., 2024</xref>; <xref ref-type="bibr" rid="bib66">Sulaiman and Lam, 2020</xref>; <xref ref-type="bibr" rid="bib77">Yamasaki et al., 2020</xref>; <xref ref-type="bibr" rid="bib82">Zeng et al., 2022a</xref>). To assess how <italic>cyaA</italic> and <italic>crp</italic> deletions affect antibiotic responses under conditions similar to those used by Zeng et al. (<xref ref-type="bibr" rid="bib83">Zeng et al., 2022b</xref>) âspecifically, exponential-phase <italic>E. coli</italic> BW25113 strains (Keio collection), lower antibiotic concentrations, and short treatments (e.g. 1 hr)âwe first tested <italic>E. coli</italic> MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains in late stationary phase using reduced antibiotic concentrations and shorter exposures. Both knockouts showed decreased survival following ampicillin and ofloxacin treatment compared to WT (<xref ref-type="supplementary-material" rid="supp6">Supplementary file 6</xref>), consistent with our findings in <xref ref-type="fig" rid="fig1">Figure 1</xref>. In the exponential phase, the knockout strains exhibited reduced survival after ampicillin treatment but increased survival after ofloxacin treatment relative to WT (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7A</xref>), again mirroring the trends in <xref ref-type="fig" rid="fig1">Figure 1</xref>. Gentamicin treatment, however, produced variable results in MG1655 knockouts, likely due to the brief 1 hr exposure being insufficient for robust conclusions (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7A</xref>). Notably, when we tested the corresponding Keio knockout strains in the BW25113 background, we observed increased tolerance in exponential-phase cells, reproducing Zeng et al.âs findings under their specific conditions (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7B</xref>), although BW25113 and MG1655 exhibited distinct persister phenotypes in exponential phase (<xref ref-type="supplementary-material" rid="supp7">Supplementary file 7A and B</xref>). These results, altogether, highlight the sensitivity of antibiotic tolerance and persistence phenotypes to factors such as strain background, antibiotic concentration, and treatment duration.</p><p>While we did not focus on the exponential growth phase in our study, it is noteworthy that the reduced growth rate during this phase in the mutant strains (<xref ref-type="fig" rid="fig4">Figure 4C</xref>) may explain the antibiotic tolerance observed in previous studies involving the <italic>cyaA</italic> deletion (<xref ref-type="bibr" rid="bib13">Chu et al., 2012</xref>; <xref ref-type="bibr" rid="bib49">Molina-Quiroz et al., 2018</xref>; <xref ref-type="bibr" rid="bib66">Sulaiman and Lam, 2020</xref>; <xref ref-type="bibr" rid="bib77">Yamasaki et al., 2020</xref>). The growth disparity noted between mutant and WT strains, particularly evident around 5 hr in our results (<xref ref-type="fig" rid="fig1s3">Figure 1âfigure supplement 3</xref>), may also be linked to the ofloxacin persisters observed in the mutant strains at this specific time point (<xref ref-type="fig" rid="fig1">Figure 1</xref>). While slow cell growth may indeed correlate with bacterial persistence (<xref ref-type="bibr" rid="bib28">Kaldalu and Tenson, 2019</xref>), it is important to note that the persistence associated with perturbations of metabolic genes cannot be solely attributed to the slow growth. In fact, the persistence of these mutant strains should depend on many factors (see <xref ref-type="supplementary-material" rid="supp5">Supplementary file 5</xref>) as reported by diverse research groups (<xref ref-type="bibr" rid="bib33">Kim et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">Luidalepp et al., 2011</xref>; <xref ref-type="bibr" rid="bib40">Ma et al., 2010</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>; <xref ref-type="bibr" rid="bib55">Pandey et al., 2021</xref>; <xref ref-type="bibr" rid="bib63">Shan et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Spoering et al., 2006</xref>; <xref ref-type="bibr" rid="bib74">Wang et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Yu et al., 2019</xref>; <xref ref-type="bibr" rid="bib80">Zalis et al., 2019</xref>). For instance, in <italic>E. coli</italic>, TCA inactivation was shown to decrease ampicillin and ofloxacin persistence during the lag phase (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>), yet it enhances gentamicin tolerance in the exponential phase, which remains unexplained by factors such as cell growth, redox activities, proton motive force (PMF), or ATP levels (<xref ref-type="bibr" rid="bib64">Shiraliyev and Orman, 2023</xref>). Furthermore, gene deletions often trigger pleiotropic effects, leading to unique tolerance mechanisms not evident in wild-type strains. In our Keio screening data analysis, we observed that the deletion of <italic>icd</italic> appeared to enhance persistence (<xref ref-type="supplementary-material" rid="supp4">Supplementary file 4</xref>), in line with a previous study (<xref ref-type="bibr" rid="bib42">Manuse et al., 2021</xref>). The <italic>icd</italic> gene encodes a TCA cycle enzyme, isocitrate dehydrogenase. While it remains unclear whether this observed outcome is attributable to other unseen pleiotropic effects stemming from the <italic>icd</italic> deletion, our data consistently indicates that the most significant reduction in persistence levels occurs with disruptions in energy metabolism. A comprehensive approach, encompassing omics and knockout screening as presented in this study, offers a more complete understanding, revealing the consensus behavior within the entire metabolic network.</p><p>Reactive oxygen species (ROS) have been proposed to contribute to antibiotic killing; however, our prior work using identical experimental conditions demonstrated that ROS are unlikely to be a major factor in persister formation during the late stationary phase (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). In that study, we overexpressed catalytically active antioxidant enzymes, including catalases (KatE, KatG) and superoxide dismutases (SodA, SodB, SodC), yet observed no significant change in persister levels. To further decouple ROS from respiratory activity in that study, we performed anaerobic experiments using nitrate as an alternative terminal electron acceptor. Interestingly, anaerobic respiration enhanced persister formation, and inhibition of nitrate reductases with KCN reduced itâfurther supporting an ROS-independent mechanism. Together, these findings suggest that under our experimental conditions, it is respiratory activity rather than ROS production that plays a more central role in antibiotic tolerance.</p><p>In conclusion, a significant gap in the current literature is the lack of a comprehensive understanding of how bacterial cell metabolism undergoes changes during the transition to a tolerant state. Identifying the specific metabolic pathways that gain significance for cell survival in this context is crucial. This knowledge can pave the way for the development of more informed and targeted treatment strategies, ultimately enhancing our ability to combat tolerant cells and improve overall treatment outcomes.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Bacterial strains and plasmids</title><p>All experiments were conducted using <italic>E. coli</italic> K-12 MG1655 wild-type (WT) and its derivative strains. <italic>E. coli</italic> K-12 MG1655, MO strains (carrying the mCherry expression system), <italic>hipA7</italic> (high persister strain), and pUA66 plasmids were obtained from Mark P. Brynildsen at Princeton University. <italic>E. coli</italic> MO strain was used to monitor cell proliferation at single cell level due to its chromosomally integrated isopropyl Î²-D-1-thiogalactopyranoside (IPTG)-inducible mCherry expression cassette (<xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>; <xref ref-type="bibr" rid="bib52">Orman and Brynildsen, 2013a</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). <italic>E. coli</italic> K-12 BW25113 WT and single deletions were obtained from Dharmacon Keio Collection (Dharmacon, Catalog# OEC4988, Lafayette, CO, USA). The mutant strains in this study were generated using the Datsenko-Wanner method (<xref ref-type="bibr" rid="bib15">Datsenko and Wanner, 2000</xref>). The pUA66-EV was generated by the removal of the <italic>gfp</italic> gene from the plasmid. The <italic>crp</italic> gene with its promoter was cloned into the modified pUA66 plasmid to obtain the pUA66-<italic>crp</italic> expression system. The <italic>sdhABCD</italic> reporter (pMSs201-P<italic><sub>sdhABCD</sub>-gfp</italic>) and the <italic>cyaA</italic> reporter (pMSs201-P<italic><sub>cyaA</sub>-gfp</italic>) were obtained from a previous study (<xref ref-type="bibr" rid="bib81">Zaslaver et al., 2006</xref>). The cloning method was followed according to a standard method from NEB (<xref ref-type="bibr" rid="bib70">Tirabassi and Bio, 2014</xref>). Genetic modifications were verified by PCR and gene sequencing (Genewiz, South Plainfield, NJ, USA). A complete list of strains, plasmids, and oligonucleotides used in this study is presented in Appendix 1âkey resources table.</p></sec><sec id="s4-2"><title>Media, chemicals, and culture conditions</title><p>All chemicals used in this study were purchased from Fisher Scientific (Atlanta, GA, USA), VWR International (Pittsburgh, PA, USA), or Sigma Aldrich (St. Louis, MO, USA). Luria-Bertani (LB) medium was prepared by combining 5 g of yeast extract, 10 g of tryptone, and 10 g of sodium chloride in 1 L of autoclaved deionized (DI) water. LB agar media was prepared by mixing 40 g of pre-mixed LB agar with 1 L of autoclaved DI water; LB agar media were used to enumerate CFUs (<xref ref-type="bibr" rid="bib5">Amato et al., 2013</xref>; <xref ref-type="bibr" rid="bib29">Keren et al., 2004a</xref>; <xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). For washing cells and removing chemicals and antibiotics before plating on agar media, 1 X Phosphate-Buffered Saline (PBS) was employed. In the persister assay, concentrations of 5 Î¼g/mL of ofloxacin (OFX), 200 Î¼g/mL of ampicillin (AMP), and 50 Î¼g/mL of gentamicin (GEN) were used (<xref ref-type="bibr" rid="bib4">Allison et al., 2011</xref>; <xref ref-type="bibr" rid="bib16">De Groote et al., 2009</xref>; <xref ref-type="bibr" rid="bib29">Keren et al., 2004a</xref>; <xref ref-type="bibr" rid="bib30">Keren et al., 2004b</xref>). The retention of plasmids necessitated 50 Î¼g/mL of kanamycin (KAN) in the culture media (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). Fluorescent protein expression was induced using 1 mM IPTG (<xref ref-type="bibr" rid="bib54">Orman and Brynildsen, 2015</xref>). Overnight pre-cultures were prepared in 14 mL Falcon test tubes containing 2 mL of LB medium, inoculated from a 25% glycerol cell stock stored at â80 Â°C, and incubated for 24 hr at 37 Â°C with shaking at 250 revolutions per minute (rpm). Main cultures were established by diluting the overnight pre-cultures at a ratio of 1:1000 into 2 mL fresh LB medium in 14 mL Falcon test tubes. Experimental cell cultures were prepared by further dilution of the main cultures into either 25 mL fresh LB medium in 250 mL baffled flasks or 2 mL fresh LB medium in 14 mL Falcon test tubes. Cultures at t=5 hr and t=24 hr were defined as early and late stationary phase cultures, respectively. Detailed experimental procedures are outlined below.</p></sec><sec id="s4-3"><title>Cell growth and persister assays</title><p>Main cultures were prepared by diluting the overnight pre-cultures at a ratio of 1:1000 into 2 mL of fresh LB medium in 14 mL Falcon test tubes. These cultures were then incubated at 37 Â°C with shaking at 250 rpm. Cell growth was monitored by measuring the optical density at 600 nm wavelength (OD<sub>600</sub>) using a Varioskan LUX Multimode Microplate Reader (Thermo Fisher, Waltham, MA, USA). The plate reader data was collected using Skanlt Software V 5.0. Cell cultures at both early and late stationary phases were collected from the test tubes and transferred to the baffled flasks to achieve ~5 Ã 10<sup>7</sup> cells/mL. This concentration represents an approximately 100-fold dilution of the WT main culture into a fresh medium within the flask. It is important to highlight that we consistently employed flow cytometry to quantify the initial cell count (refer to the section âMonitoring cell divisionâ for comprehensive details). As needed, adjustments in cell number-to-volume were executed to ensure the same cell number among both WT and mutant strains. These cultures were then treated with antibiotics at the indicated concentrations and were cultured with shaking at 37 Â°C for 20 hr. After treatment, a 1 â¯mL sample from each flask was transferred to a microcentrifuge tube for a rigorous washing protocol to minimize antibiotic carryover. The samples were centrifuged at 13,300 RPM (17,000 Ã <italic>g</italic>) for 3 min, and &gt;950 â¯ÂµL of supernatant was carefully removed without disturbing the pellet. The pellet was then resuspended in 950 â¯ÂµL of PBS, achieving a &gt;20-fold dilution of residual antibiotics. This wash step was repeated once more, resulting in a cumulative &gt;400-fold dilution. After the final wash, cells were resuspended in 100 â¯ÂµL of PBS. A 10 â¯ÂµL aliquot of this suspension was serially diluted in a 96-well round-bottom plate, and 10 â¯ÂµL from each dilution was spotted onto an agar plate. The remaining 90 â¯ÂµL of the sample was also plated to quantify CFU levels around the limit of detection, (~1 â¯CFU/mL). Plates were incubated at 37 â¯Â°C for 16 hr (or up to 48 hr) to allow CFUs to develop. When necessary, this washing procedure was repeated up to six times to assess its impact on CFU recovery.</p></sec><sec id="s4-4"><title>Mid-exponential phase persister assays</title><p>Overnight cultures of <italic>E. coli</italic> K-12 MG1655 or BW25113 WT, and mutant strains were diluted 1:100 in 2 mL of LB medium in 14 mL Falcon tubes and incubated at 37 Â°C with shaking at 250 rpm. At mid-exponential phase (OD<sub>600</sub>~0.25), cells were challenged with the indicated antibiotics and concentrations. At designated time points, cells (1 mL) were collected, washed with 1 X PBS, and plated on agar to determine colony-forming units (CFU). To quantify the initial cell count, 10 ÂµL of the culture before treatments was serially diluted and plated on LB agar. CFU levels were assessed after incubating the plates for at least 16 hr at 37 Â°C.</p></sec><sec id="s4-5"><title>cAMP profile assay</title><p>An overnight pre-culture of <italic>E. coli</italic> K-12 MG1655 WT was prepared in test tubes with 2 mL of LB medium. The culture was incubated at 37 Â°C with shaking at 250 rpm for 24 hr. For the experimental cultures, a 1:1000 dilution was made in fresh medium. At time points 0, 2, 4, 6, 8, and 24 hr, 100 Î¼L of the experimental culture was washed with cold 1 X PBS. After centrifuging at 13,300 rpm (17,000 x <italic>g</italic>), the supernatant was removed. The cells were then resuspended in 100 Î¼L of cell lysis buffer from the Cyclic AMP XP Assay Kit (Catalog# 4339 S, Cell Signaling Technology, Danvers, MA, USA) on ice for 10 min. Next, 50 ÂµL of lysed cells was mixed with the kitâs horseradish peroxidase (HRP)-linked cAMP solution in the cAMP assay plate. This mixture was incubated at room temperature for 3 hr on a plate shaker at 250 rpm. Following the 3 hr incubation, the plate content was discarded, and the plate was washed four times with the kitâs Wash Buffer. Then, 100 ÂµL of tetramethylbenzidine (TMB) substrate was added to allow color development, and after 30 min, 100 ÂµL of the stop solution provided by the kit was added. The absorbance was measured at 450 nm using a plate reader. The standard curve was prepared using the same conditions and the standard cAMP solutions provided by the kit to determine cAMP concentrations.</p></sec><sec id="s4-6"><title>Metabolomics</title><p>Metabolites from both Î<italic>crp</italic> and WT cells were analyzed at the Metabolon, Inc facility (Morrisville, NC, USA). Cells were cultured until the early stationary phase and late stationary phase at 37 Â°C with shaking at 250 rpm. Afterward, cells were collected through centrifugation at 4700 rpm at 37 Â°C for 15 min, yielding a pellet of approximately 100 Î¼L containing around 10<sup>10</sup> cells. Subsequently, the cells were washed once with 1 X PBS and then centrifuged (13,000 rpm, 3 min at 4 Â°C). Following this, they were frozen in an ethanol/dry ice bath for 10 min. The extracts from both mutant and WT cells were subjected to analysis using ultra-high-performance liquid chromatography-tandem accurate mass spectrometry (MS), a process aimed at identifying a wide range of metabolites. Sample extraction, preparation, instrument settings, and conditions for the MS platform adhered to Metabolonâs protocols (as detailed in our previous study) (<xref ref-type="bibr" rid="bib46">Mohiuddin et al., 2022</xref>). To identify the sampleâs metabolites among potential false positives from instrument noise, process artifacts, and redundant ion features, the results were cross-referenced with Metabolonâs extensive metabolite library (standards). Data normalization was carried out based on protein concentration, determined using the Bradford assay. The significant difference between mutant and WT was identified using Welchâs two-sample t-test. Further analysis involved pathway enrichment assessment using MetaboAnalyst (<xref ref-type="bibr" rid="bib38">Lu et al., 2023</xref>). This involved inputting the upregulated and downregulated metabolites based on chosen thresholds. A comprehensive overview of metabolite measurements, pathway enrichment, statistical analyses, and data representations can be found in our previously published study (<xref ref-type="bibr" rid="bib46">Mohiuddin et al., 2022</xref>).</p></sec><sec id="s4-7"><title>Proteomics</title><p>Overnight cultures for both <italic>E. coli</italic> K-12 MG1655 WT and Î<italic>crp</italic> strains were prepared using 2 mL of LB medium. Incubation was carried out at 37 Â°C and 250 rpm for 24 hr. The following day, the main cultures were established under the same conditions, using a 1000-fold dilution of the overnight culture in 2 mL fresh LB medium. After 24 hours, the OD<sub>600</sub> of both WT and mutant strains was measured and adjusted to an OD<sub>600</sub> of 2.5. For further processing, 2 mL of the main culture was washed twice with cold 1 X PBS, maintaining the cold environment throughout. Centrifugation conditions were set at 4 Â°C, 13,000 rpm for 3 min. Before the final centrifugation, a cell count was conducted using flow cytometry. This involved using 10 ÂµL of washed culture and 990 ÂµL of 1 X PBS. Subsequent to centrifugation, the pellets were collected. Cell lysis was carried out using 300 ÂµL of NEBExpress <italic>E. coli</italic> Lysis Reagent (Catalog# P8116S, Ipswich, MA, USA) at room temperature for 30 mins. Following this, the lysed samples were centrifuged at 16,600 x <italic>g</italic> for 10 min, and 250 ÂµL of supernatants were collected from each sample for the assay. The total protein concentration of the supernatants was determined using the bicinchoninic acid (BCA) assay (Catalog# 23225, Thermo Fisher Scientific, Waltham, MA, USA). In a 96-well plate, 25 ÂµL of each cell lysate sample, diluted 5 and 10 times with ultra-pure DI water, were loaded into each well. Subsequently, 200 ÂµL of the BCA working reagent (50:1, Reagent A:B) was added to each well and mixed on a plate shaker for 30 s. The plate was then incubated at 37 Â°C for 30 min, followed by cooling for 5 min at room temperature, shielded from light. The absorbance was finally measured at 562 nm using a plate reader, and the total protein concentration in each sample was calculated using a standard curve prepared from standard protein solutions. Protein analysis for both WT and mutant was conducted by the proteomics service at UT Healthâs Clinical and Translational Proteomics Service Center (Houston, TX). The samples underwent acetone precipitation, during which proteins were precipitated by exposing them to â20 Â°C for 3 hours. Following this, a centrifugation step at 12,000 x <italic>g</italic> for 5 min separated the precipitated pellets. These pellets were subsequently subjected to denaturation and reduction using a mixture containing 30 Î¼L of 6 M urea, 20 mM DTT in 150 mM Tris HCl (pH 8.0) at 37 Â°C for 40 min. Afterward, alkylation was carried out with 40 mM iodoacetamide in the absence of light for 30 min. To prepare for digestion, the reaction mixture was diluted 10-fold using 50 mM Tris-HCl (pH 8.0) and then incubated overnight at 37 Â°C with trypsin at a 1:30 enzyme-to-substrate ratio. The digestion process was terminated by adding an equal volume of 2% formic acid, followed by desalting using Waters Oasis HLB 1 mL reverse phase cartridges, following the vendorâs recommended procedure. Finally, the elutes were dried using vacuum centrifugation. Approximately 1 Âµg of the tryptic digest, prepared in a solution containing 2% acetonitrile and 0.1% formic acid in water, underwent analysis using LC/MS/MS. The instrument used was the Orbitrap Fusion Tribrid mass spectrometer by Thermo Fisher Scientific, connected to a Dionex UltiMate 3000 Binary RSLCnano System. The separation of peptides occurred on an analytical C18 column with dimensions of 100 Î¼m ID x 25 cm, featuring 5 Î¼m particles and an 18 Ã pore size. Peptides were eluted at a flow rate of 350 nL/min. The gradient conditions applied were as follows: a gradient starting from 3% B and increasing to 22% B over a duration of 90 min, followed by a step to 22â35% B for 10 min, then another step to 35â90% B for 10 min, and finally, maintaining 90% B for an additional 10 min (Solvent A was composed of 0.1% formic acid in water, while solvent B contained 0.1% formic acid in acetonitrile). The peptides were analyzed using a data-dependent acquisition method. The Orbitrap Fusion MS operated by measuring FTMS1 spectra with a resolution of 120,000 FWHM, scanning in the m/z range of 350â1500, using an AGC target set to 2E5, and with a maximum injection time of 50ms. Within a maximum cycle time of 3 s, ITMS2 spectra were collected in rapid scan mode. High Collision Dissociation (HCD) was employed with a normalized collision energy (NCE) of 34, an isolation window of 1.6 m/z, an AGC target set to 1E4, and a maximum injection time of 35ms. Dynamic exclusion was implemented for a duration of 35 s to prevent repeated analysis of the same ions. For the experimental analysis, the Thermo Fisher Scientific Proteome Discoverer software version 1.4 was utilized to process the raw data files. The spectra were subjected to analysis against the <italic>E. coli</italic> proteome database (Swiss-Prot 29,161) through the Sequest HT search engine. Additionally, the spectra were compared against a decoy database, employing a target false discovery rate (FDR) of 1% for stringent criteria and 5% for more relaxed criteria. The enzymatic cleavage allowance for trypsin included up to two potential missed cleavages. The MS tolerance was defined as 10 ppm, while the MS/MS tolerance was set at 0.6 Da. Fixed modification involved carbamidomethylation on cysteine residues, and variable modifications encompassed methionine oxidation and asparagine deamidation. For proteomics data processing and fold change calculations, the approaches were essentially followed by the method paper from <xref ref-type="bibr" rid="bib2">Aguilan et al., 2020</xref>. Then, the STRING tool V12.0 (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>) was employed to find the significant networks among input proteins. To generate the protein network and pathway enrichment analysis, we input the protein identifiers (Accession numbers) for upregulated or downregulated proteins with at least a twofold increase or reduction, respectively. <italic>E. coli</italic> K-12 was selected as the organism of interest. We opted for evidence as the criterion for network edges, prioritizing the type of interaction evidence, helping us conduct an automated pathway-enrichment analysis, centering on the entered proteins and identifying pathways that occurred more frequently than expected. This analysis was grounded in the statistical background of the entire genome and encompasses various functional pathway classification frameworks, such as Gene Ontology annotations, KEGG pathways, and Uniprot keywords, as detailed elsewhere (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>). In pathway enrichment analysis, the âstrength scoreâ, calculated as Log<sub>10</sub>(observed/expected), serves to assess the degree or significance of enrichment within a specific biological pathway. This metric reflects the magnitude of the enrichment effect, with a higher score indicating stronger enrichment. The score is derived from the ratio of (i) annotated proteins in the network for a given term to (ii) the expected number of proteins annotated with the same term in a random network of equivalent size (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>). To gauge the significance of enrichment, False Discovery Rate (FDR) is employed. FDR scores represent p-values corrected for multiple testing within each category using the BenjaminiâHochberg procedure (<xref ref-type="bibr" rid="bib67">Szklarczyk et al., 2021</xref>; <xref ref-type="bibr" rid="bib68">Szklarczyk et al., 2023</xref>).</p></sec><sec id="s4-8"><title>Monitoring cell division</title><p>To monitor cell division and quantify non-growing cells, we utilized inducible fluorescent protein (mCherry) expression. Overnight pre-cultures of <italic>E. coli</italic> MO were prepared with 2 mL of LB medium containing 1 mM of IPTG. These cultures were grown in test tubes at 37 Â°C with shaking at 250 rpm for 24 hr. Main cultures were established by diluting the overnight pre-cultures (at a ratio of 1:1000) into 2 mL of fresh LB medium in 14 mL Falcon test tubes. These cultures were incubated at 37 Â°C with shaking at 250 rpm. Cells were allowed to grow until they reached the early stationary phase and the late stationary phase. The mCherry-positive cells were then collected, washed twice with 1 X PBS to remove the IPTG from the culture, and subsequently re-suspended in fresh 2 ml LB media in test tubes to achieve ~5 Ã 10<sup>7</sup> cells/mL. This concentration represents an approximately 100-fold dilution. When needed, adjustments in cell number-to-volume were made to ensure the same cell number among both WT and mutant strains. In the experimental culture test tubes, 2 mL of LB medium was added, and the volume of washed cells was inoculated to achieve an OD<sub>600</sub> of 0.0286. The culture was then incubated at 37 Â°C with shaking at 250 rpm. At specific time points (0, 1, 2, and 2.5 hr), cells were collected and re-suspended in 1 X PBS to measure their fluorescent protein content using flow cytometry. For flow cytometry analysis, cells were collected and diluted to a desired cell density (~10<sup>6</sup>â10<sup>7</sup> cells/mL) in 1 mL of 1 X PBS in flow cytometry tubes (5 mL round-bottom Falcon tubes, size: 12x75 mm). The flow cytometry analysis was conducted using a NovoCyte 3000RYB instrument (ACEA Bioscience Inc, San Diego, CA, USA). During flow cytometry analysis, a slow sample flow rate of 14 Î¼L/min was chosen, along with a sample stream diameter (core diameter) of 7.7 Î¼m. The instrument maintained a constant sheath flow rate of 6.5 mL/min. The core diameter was calculated using the ratio of the sample flow rate to the sheath flow rate. These specific conditions were selected to achieve improved data resolution for the size of <italic>E. coli</italic> cells. Flow diagrams utilized forward and side scatter signals from viable cells, alongside a control of solvent devoid of cells, to ascertain the presence of cells. For the flow cytometry analysis, cells were excited at a 561 nm wavelength, and the red fluorescence was detected using a 615/20 nm bandpass filter.</p></sec><sec id="s4-9"><title>Flow cytometry analysis of cell growth</title><p>Overnight cultures of <italic>E. coli</italic> K-12 MG1655 MO WT and mutant strains were diluted at a ratio of 1:1000 into 2 mL of fresh LB medium, placed in 14 mL Falcon test tubes, and incubated at 37 Â°C with shaking at 250 rpm for 24 hr. For the main cultures, a similar strategy was employed. The cultures were diluted at a ratio of 1:100 into 2 mL of fresh LB medium in 14 mL Falcon test tubes. These cultures were then incubated at 37 Â°C with shaking at 250 rpm. At specific time points, including t=0, 20 min, 40 min, and 1â5 hr, the cell growth was halted. This was achieved by diluting the cells in 1 X PBS containing 25 Î¼g/mL of chloramphenicol (CAM). The CAM treatment allowed for subsequent analysis without further division. Flow cytometry was then utilized to measure the number of cells at each of these time points. This approach provided insight into cell division dynamics and allowed for the quantification of cell populations under specific conditions.</p></sec><sec id="s4-10"><title>Fluorescent protein expression assay for reporter genes</title><p>Mutant and control strains were derived from <italic>E. coli</italic> K-12 MG1655 and carried pMSs201-<italic>gfp</italic> plasmids incorporating P<italic><sub>sdhABCD</sub></italic> or P<italic><sub>cyaA</sub></italic> gene promoters. Overnight pre-cultures were prepared using 2 mL of LB medium supplemented with 50 Î¼g/mL KAN. These cultures were incubated in test tubes within a shaker at 37 Â°C for 24 hr. Main cultures were established by diluting the overnight pre-cultures at a ratio of 1:1000 into 2 mL of fresh LB medium within 14 mL Falcon test tubes. These main cultures were maintained at 37 Â°C with shaking at 250 rpm. Cell cultures at the desired growth phase were collected and then diluted to attain a desired cell density of around 10<sup>6</sup>â10<sup>7</sup> cells/mL in 1 mL of 1 X PBS within flow cytometry tubes. This allowed for subsequent flow cytometry analysis, using the same conditions as described earlier for monitoring cell division (refer to âMonitoring cell divisionâ). During analysis, a laser emitting light at 488 nm was used to excite the cells, and the resulting green fluorescence was detected using a 530/30 nm bandpass filter. This setup enabled the examination of the fluorescence patterns of the cells, offering insights into their dynamics under different conditions.</p></sec><sec id="s4-11"><title>Redox Sensor Green assay</title><p>To gauge bacterial metabolic activity, we employed the Redox Sensor Green (RSG) dye from Thermo Fisher (Catalog# B34954, Thermo Fisher Scientific, Waltham, MA). <italic>E. coli</italic> K-12 MG1655 WT and mutant cells from the desired growth phase were diluted at a ratio of 1:100 in 1 mL of 1 X PBS. To this solution, 1 Î¼L of the RSG dye was added to flow cytometry tubes. After a brief vortexing to ensure uniform mixing, the samples were incubated at 37 Â°C in darkness for 10 min. Subsequently, these samples were subjected to flow cytometry analysis. For the flow cytometry analysis, the same methodology as employed in âMonitoring cell divisionâ was followed, with one variation. Cells were excited at 488 nm during analysis, and the resulting green fluorescence was detected using a 530/30 nm bandpass filter. This setup allowed us to assess the fluorescence patterns, reflecting the metabolic activity of the bacterial cells under different conditions. As a control measure, cells were treated with 20 Î¼M of carbonyl cyanide m-chlorophenyl hydrazone (CCCP) for 5 min before the addition of the RSG dye. This served to validate the assayâs sensitivity to changes in metabolic activity (<xref ref-type="fig" rid="fig5s1">Figure 5âfigure supplement 1</xref>).</p></sec><sec id="s4-12"><title>Metabolic activity of non-lysing cells and VBNC cell quantification</title><p>Overnight cultures of <italic>E. coli</italic> K-12 MG1655 MO WT and mutant strains were diluted at a ratio of 1:1000 into 2 mL of fresh LB medium supplemented with 1 mM IPTG. These cultures were established in 14 mL Falcon test tubes and incubated at 37 Â°C with shaking at 250 rpm for 24 hr. Treatment cultures were prepared by diluting the main cultures at a ratio of 1:100 into 25 mL of fresh LB medium supplemented with 1 mM IPTG. These cultures were set up in 250 mL baffled flasks and contained 200 Î¼g/mL AMP. They were then cultured at 37 Â°C with shaking at 250 rpm for 20 hr. Both before and after the treatment, 1 mL samples were collected from the cultures. These samples were subjected to a washing procedure with 1 X PBS to eliminate the antibiotic present in the samples. The washed cells were then resuspended in 1 mL of 1 X PBS within flow cytometry tubes. To measure the metabolic activity of the non-lysing cells, the RSG dye was employed as described above. Intact cells (following antibiotic treatment), stained as live with RSG, comprised both persister and VBNC cells. Persister levels were quantified by plating the cells on an agar medium, as described previously (<xref ref-type="bibr" rid="bib53">Orman and Brynildsen, 2013b</xref>). As VBNC cells cannot grow on agar medium, their enumeration involved subtracting the number of persister cells from the total number of intact cells.</p></sec><sec id="s4-13"><title>Screening <italic>E. coli</italic> (K-12 BW25113) Keio knockout collection</title><p>Overnight cultures of individual mutant strains, along with their parental strain K-12 BW25113 WT harboring a kanamycin-resistant marker, were diluted at a ratio of 1:1000 in fresh LB medium containing 50 Î¼g/mL of KAN. This was done in 14 mL Falcon test tubes and the cultures were then incubated at 37 Â°C with shaking at 250 rpm. Upon reaching the late stationary phase, cells were further diluted at a ratio of 1:100 in fresh medium supplemented with antibiotics at specified concentrations. These cultures were once again incubated at 37 Â°C with shaking for 20 hr. Following the 20 hr treatment period, the same methodology described in the section âCell growth and persister assaysâ was employed to quantify the number of persisters. This approach allowed for an assessment of the impact of antibiotics on the formation of persister cells for both mutant strains and the parental K-12 BW25113 WT strain.</p></sec><sec id="s4-14"><title>Persister quantitation in <italic>E. coli</italic> K-12 MG1655 single gene deletions</title><p>Overnight cultures of mutant strains were diluted at a ratio of 1:1000 in 14 mL Falcon test tubes containing 2 mL of LB medium. These cultures were then incubated at 37 Â°C with shaking at 250 rpm. Upon reaching the late stationary phase, cells were diluted at a ratio of 1:100 in fresh medium supplemented with antibiotics at specified concentrations. The cultures were once again subjected to shaking at 37 Â°C for 20 hr. The same method described earlier, referred to as âCell growth and persister assaysâ, was employed to quantify the number of persister cells resulting from this treatment. This approach allowed for the assessment of the impact of antibiotic exposure on persister cell formation within the mutant strains.</p></sec><sec id="s4-15"><title>Statistics and reproducibility</title><p>A nonlinear logarithmic model was employed to create biphasic kill curves (<xref ref-type="bibr" rid="bib44">Mohiuddin et al., 2020a</xref>; <xref ref-type="bibr" rid="bib76">Windels et al., 2019</xref>). The significance of these kill curves was determined through the utilization of F-statistics (<xref ref-type="bibr" rid="bib44">Mohiuddin et al., 2020a</xref>; <xref ref-type="bibr" rid="bib76">Windels et al., 2019</xref>). Metabolomics data were subjected to analysis using Welchâs two-sample t-test in order to identify metabolites that significantly differed between the control and mutant groups (<xref ref-type="bibr" rid="bib79">Yuen, 1974</xref>). For all experiments, a minimum of three independent biological replicates were conducted, unless explicitly stated otherwise. In each figure (excluding flow diagrams), the data for each time point are represented as the mean value accompanied by the standard deviation. In terms of statistical significance analysis, the designated threshold values for p were set as follows: *p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001. All figures were generated using GraphPad Prism 10.3.0. The statistical analyses were carried out using the statistical functions of GraphPad Prism 10.3.0. For the clustering of metabolomics and proteomics data, the âClustergramâ function of MATLAB (V R2020b) was employed. FlowJo (V 10.8.1) was the tool used to analyze the data acquired from flow cytometry.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Validation, Investigation, Methodology, Writing â original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Methodology, Writing â original draft, Writing â review and editing</p></fn><fn fn-type="con" id="con3"><p>Software, Formal analysis, Validation, Methodology</p></fn><fn fn-type="con" id="con4"><p>Conceptualization, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing â original draft, Project administration, Writing â review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>MIC of antibiotics and concentrations of bactericidal antibiotics used in persister assays.</title></caption><media xlink:href="elife-99735-supp1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Analyzed metabolomics data.</title></caption><media xlink:href="elife-99735-supp2-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>Analyzed proteomics data.</title></caption><media xlink:href="elife-99735-supp3-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp4"><label>Supplementary file 4.</label><caption><title>Analyzed persister survival fraction data.</title></caption><media xlink:href="elife-99735-supp4-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp5"><label>Supplementary file 5.</label><caption><title>The knockout strains generated using the <italic>E. coli</italic> K-12 MG1655 background in this study.</title></caption><media xlink:href="elife-99735-supp5-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp6"><label>Supplementary file 6.</label><caption><title>Persister levels of <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains in late stationary phase.</title></caption><media xlink:href="elife-99735-supp6-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp7"><label>Supplementary file 7.</label><caption><title>Persister levels of <italic>E. coli</italic> K-12 MG1655 (A) and BW25113 (B) WT, Î<italic>crp</italic>, and Î<italic>cyaA</italic> strains in the exponential growth phase.</title></caption><media xlink:href="elife-99735-supp7-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-99735-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analyzed during this study are included in the manuscript and supporting files.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We would like to express our gratitude to the members of Dr. Ormanâs laboratory for their support and assistance throughout this study. We also thank Metabolon, Inc for their expertise in metabolomics experiments and data analysis, as well as UT Healthâs Clinical and Translational Proteomics Service Center for their contribution to the proteomics experiments.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>KN</given-names></name><name><surname>Takaki</surname><given-names>K</given-names></name><name><surname>Connolly</surname><given-names>LE</given-names></name><name><surname>Wiedenhoft</surname><given-names>H</given-names></name><name><surname>Winglee</surname><given-names>K</given-names></name><name><surname>Humbert</surname><given-names>O</given-names></name><name><surname>Edelstein</surname><given-names>PH</given-names></name><name><surname>Cosma</surname><given-names>CL</given-names></name><name><surname>Ramakrishnan</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism</article-title><source>Cell</source><volume>145</volume><fpage>39</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.022</pub-id><pub-id pub-id-type="pmid">21376383</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguilan</surname><given-names>JT</given-names></name><name><surname>Kulej</surname><given-names>K</given-names></name><name><surname>Sidoli</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Guide for protein fold change and p-value calculation for non-experts in proteomics</article-title><source>Molecular Omics</source><volume>16</volume><fpage>573</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1039/d0mo00087f</pub-id><pub-id pub-id-type="pmid">32968743</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiba</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Transcription of the <italic>Escherichia coli</italic> adenylate cyclase gene is negatively regulated by cAMP-cAMP receptor protein</article-title><source>The Journal of Biological Chemistry</source><volume>260</volume><fpage>3063</fpage><lpage>3070</lpage><pub-id pub-id-type="doi">10.1016/S0021-9258(18)89473-X</pub-id><pub-id pub-id-type="pmid">2982847</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allison</surname><given-names>KR</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name><name><surname>Collins</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Metabolite-enabled eradication of bacterial persisters by aminoglycosides</article-title><source>Nature</source><volume>473</volume><fpage>216</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1038/nature10069</pub-id><pub-id pub-id-type="pmid">21562562</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>SM</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Metabolic control of persister formation in <italic>Escherichia coli</italic></article-title><source>Molecular Cell</source><volume>50</volume><fpage>475</fpage><lpage>487</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.04.002</pub-id><pub-id pub-id-type="pmid">23665232</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>SM</given-names></name><name><surname>Fazen</surname><given-names>CH</given-names></name><name><surname>Henry</surname><given-names>TC</given-names></name><name><surname>Mok</surname><given-names>WWK</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name><name><surname>Sandvik</surname><given-names>EL</given-names></name><name><surname>Volzing</surname><given-names>KG</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of metabolism in bacterial persistence</article-title><source>Frontiers in Microbiology</source><volume>5</volume><elocation-id>70</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2014.00070</pub-id><pub-id pub-id-type="pmid">24624123</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnoldini</surname><given-names>M</given-names></name><name><surname>Vizcarra</surname><given-names>IA</given-names></name><name><surname>PeÃ±a-Miller</surname><given-names>R</given-names></name><name><surname>Stocker</surname><given-names>N</given-names></name><name><surname>Diard</surname><given-names>M</given-names></name><name><surname>Vogel</surname><given-names>V</given-names></name><name><surname>Beardmore</surname><given-names>RE</given-names></name><name><surname>Hardt</surname><given-names>WD</given-names></name><name><surname>Ackermann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Bistable expression of virulence genes in <italic>Salmonella</italic> leads to the formation of an antibiotic-tolerant subpopulation</article-title><source>PLOS Biology</source><volume>12</volume><elocation-id>e1001928</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1001928</pub-id><pub-id pub-id-type="pmid">25136970</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayrapetyan</surname><given-names>M</given-names></name><name><surname>Williams</surname><given-names>T</given-names></name><name><surname>Oliver</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Relationship between the viable but nonculturable state and antibiotic persister cells</article-title><source>Journal of Bacteriology</source><volume>200</volume><elocation-id>e00249-18</elocation-id><pub-id pub-id-type="doi">10.1128/JB.00249-18</pub-id><pub-id pub-id-type="pmid">30082460</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baba</surname><given-names>T</given-names></name><name><surname>Ara</surname><given-names>T</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Takai</surname><given-names>Y</given-names></name><name><surname>Okumura</surname><given-names>Y</given-names></name><name><surname>Baba</surname><given-names>M</given-names></name><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Tomita</surname><given-names>M</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Construction of <italic>Escherichia coli</italic> K-12 in-frame, single-gene knockout mutants: the Keio collection</article-title><source>Molecular Systems Biology</source><volume>2</volume><elocation-id>2006.0008</elocation-id><pub-id pub-id-type="doi">10.1038/msb4100050</pub-id><pub-id pub-id-type="pmid">16738554</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balaban</surname><given-names>NQ</given-names></name><name><surname>Merrin</surname><given-names>J</given-names></name><name><surname>Chait</surname><given-names>R</given-names></name><name><surname>Kowalik</surname><given-names>L</given-names></name><name><surname>Leibler</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bacterial persistence as a phenotypic switch</article-title><source>Science</source><volume>305</volume><fpage>1622</fpage><lpage>1625</lpage><pub-id pub-id-type="doi">10.1126/science.1099390</pub-id><pub-id pub-id-type="pmid">15308767</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>TC</given-names></name><name><surname>Mok</surname><given-names>WWK</given-names></name><name><surname>Murawski</surname><given-names>AM</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1177</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09058-4</pub-id><pub-id pub-id-type="pmid">30862812</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bettenbrock</surname><given-names>K</given-names></name><name><surname>Sauter</surname><given-names>T</given-names></name><name><surname>Jahreis</surname><given-names>K</given-names></name><name><surname>Kremling</surname><given-names>A</given-names></name><name><surname>Lengeler</surname><given-names>JW</given-names></name><name><surname>Gilles</surname><given-names>ED</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Correlation between growth rates, EIIACrr phosphorylation, and intracellular cyclic AMP levels in <italic>Escherichia coli</italic> K-12</article-title><source>Journal of Bacteriology</source><volume>189</volume><fpage>6891</fpage><lpage>6900</lpage><pub-id pub-id-type="doi">10.1128/JB.00819-07</pub-id><pub-id pub-id-type="pmid">17675376</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>W</given-names></name><name><surname>Zere</surname><given-names>TR</given-names></name><name><surname>Weber</surname><given-names>MM</given-names></name><name><surname>Wood</surname><given-names>TK</given-names></name><name><surname>Whiteley</surname><given-names>M</given-names></name><name><surname>Hidalgo-Romano</surname><given-names>B</given-names></name><name><surname>Valenzuela</surname><given-names>E</given-names><suffix>Jr</suffix></name><name><surname>McLean</surname><given-names>RJC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Indole production promotes <italic>Escherichia coli</italic> mixed-culture growth with <italic>Pseudomonas aeruginosa</italic> by inhibiting quorum signaling</article-title><source>Applied and Environmental Microbiology</source><volume>78</volume><fpage>411</fpage><lpage>419</lpage><pub-id pub-id-type="doi">10.1128/AEM.06396-11</pub-id><pub-id pub-id-type="pmid">22101045</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conlon</surname><given-names>BP</given-names></name><name><surname>Rowe</surname><given-names>SE</given-names></name><name><surname>Gandt</surname><given-names>AB</given-names></name><name><surname>Nuxoll</surname><given-names>AS</given-names></name><name><surname>Donegan</surname><given-names>NP</given-names></name><name><surname>Zalis</surname><given-names>EA</given-names></name><name><surname>Clair</surname><given-names>G</given-names></name><name><surname>Adkins</surname><given-names>JN</given-names></name><name><surname>Cheung</surname><given-names>AL</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Persister formation in <italic>Staphylococcus aureus</italic> is associated with ATP depletion</article-title><source>Nature Microbiology</source><volume>1</volume><elocation-id>16051</elocation-id><pub-id pub-id-type="doi">10.1038/nmicrobiol.2016.51</pub-id><pub-id pub-id-type="pmid">27572649</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Datsenko</surname><given-names>KA</given-names></name><name><surname>Wanner</surname><given-names>BL</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>One-step inactivation of chromosomal genes in <italic>Escherichia coli</italic> K-12 using PCR products</article-title><source>PNAS</source><volume>97</volume><fpage>6640</fpage><lpage>6645</lpage><pub-id pub-id-type="doi">10.1073/pnas.120163297</pub-id><pub-id pub-id-type="pmid">10829079</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Groote</surname><given-names>VN</given-names></name><name><surname>Verstraeten</surname><given-names>N</given-names></name><name><surname>Fauvart</surname><given-names>M</given-names></name><name><surname>Kint</surname><given-names>CI</given-names></name><name><surname>Verbeeck</surname><given-names>AM</given-names></name><name><surname>Beullens</surname><given-names>S</given-names></name><name><surname>Cornelis</surname><given-names>P</given-names></name><name><surname>Michiels</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Novel persistence genes in <italic>Pseudomonas aeruginosa</italic> identified by high-throughput screening</article-title><source>FEMS Microbiology Letters</source><volume>297</volume><fpage>73</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01657.x</pub-id><pub-id pub-id-type="pmid">19508279</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deutscher</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The mechanisms of carbon catabolite repression in bacteria</article-title><source>Current Opinion in Microbiology</source><volume>11</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.mib.2008.02.007</pub-id><pub-id pub-id-type="pmid">18359269</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fic</surname><given-names>E</given-names></name><name><surname>Bonarek</surname><given-names>P</given-names></name><name><surname>Gorecki</surname><given-names>A</given-names></name><name><surname>Kedracka-Krok</surname><given-names>S</given-names></name><name><surname>Mikolajczak</surname><given-names>J</given-names></name><name><surname>Polit</surname><given-names>A</given-names></name><name><surname>Tworzydlo</surname><given-names>M</given-names></name><name><surname>Dziedzicka-Wasylewska</surname><given-names>M</given-names></name><name><surname>Wasylewski</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>cAMP receptor protein from <italic>Escherichia coli</italic> as a model of signal transduction in proteins â a review</article-title><source>Microbial Physiology</source><volume>17</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1159/000178014</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname><given-names>RA</given-names></name><name><surname>Gollan</surname><given-names>B</given-names></name><name><surname>Helaine</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Persistent bacterial infections and persister cells</article-title><source>Nature Reviews. Microbiology</source><volume>15</volume><fpage>453</fpage><lpage>464</lpage><pub-id pub-id-type="doi">10.1038/nrmicro.2017.42</pub-id><pub-id pub-id-type="pmid">28529326</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goormaghtigh</surname><given-names>F</given-names></name><name><surname>Van Melderen</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Single-cell imaging and characterization of <italic>Escherichia coli</italic> persister cells to ofloxacin in exponential cultures</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaav9462</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aav9462</pub-id><pub-id pub-id-type="pmid">31223653</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>GÃ¶rke</surname><given-names>B</given-names></name><name><surname>StÃ¼lke</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Carbon catabolite repression in bacteria: many ways to make the most out of nutrients</article-title><source>Nature Reviews. Microbiology</source><volume>6</volume><fpage>613</fpage><lpage>624</lpage><pub-id pub-id-type="doi">10.1038/nrmicro1932</pub-id><pub-id pub-id-type="pmid">18628769</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanahan</surname><given-names>D</given-names></name><name><surname>Weinberg</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hallmarks of cancer: the next generation</article-title><source>Cell</source><volume>144</volume><fpage>646</fpage><lpage>674</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.02.013</pub-id><pub-id pub-id-type="pmid">21376230</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofsteenge</surname><given-names>N</given-names></name><name><surname>van Nimwegen</surname><given-names>E</given-names></name><name><surname>Silander</surname><given-names>OK</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of <italic>E. coli</italic></article-title><source>BMC Microbiology</source><volume>13</volume><elocation-id>25</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2180-13-25</pub-id><pub-id pub-id-type="pmid">23379956</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hossain</surname><given-names>T</given-names></name><name><surname>Singh</surname><given-names>A</given-names></name><name><surname>Butzin</surname><given-names>NC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title><italic>Escherichia coli</italic> cells are primed for survival before lethal antibiotic stress</article-title><source>Microbiology Spectrum</source><volume>11</volume><elocation-id>e0121923</elocation-id><pub-id pub-id-type="doi">10.1128/spectrum.01219-23</pub-id><pub-id pub-id-type="pmid">37698413</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huemer</surname><given-names>M</given-names></name><name><surname>Mairpady Shambat</surname><given-names>S</given-names></name><name><surname>Brugger</surname><given-names>SD</given-names></name><name><surname>Zinkernagel</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Antibiotic resistance and persistence-Implications for human health and treatment perspectives</article-title><source>EMBO Reports</source><volume>21</volume><elocation-id>e51034</elocation-id><pub-id pub-id-type="doi">10.15252/embr.202051034</pub-id><pub-id pub-id-type="pmid">33400359</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>JÃµers</surname><given-names>A</given-names></name><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Tenson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The frequency of persisters in <italic>Escherichia coli</italic> reflects the kinetics of awakening from dormancy</article-title><source>Journal of Bacteriology</source><volume>192</volume><fpage>3379</fpage><lpage>3384</lpage><pub-id pub-id-type="doi">10.1128/JB.00056-10</pub-id><pub-id pub-id-type="pmid">20435730</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>JÃµers</surname><given-names>A</given-names></name><name><surname>Tenson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Growth resumption from stationary phase reveals memory in <italic>Escherichia coli</italic> cultures</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>24055</elocation-id><pub-id pub-id-type="doi">10.1038/srep24055</pub-id><pub-id pub-id-type="pmid">27048851</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Tenson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Slow growth causes bacterial persistence</article-title><source>Science Signaling</source><volume>12</volume><elocation-id>1167</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.aay1167</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname><given-names>I</given-names></name><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Spoering</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004a</year><article-title>Persister cells and tolerance to antimicrobials</article-title><source>FEMS Microbiology Letters</source><volume>230</volume><fpage>13</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/S0378-1097(03)00856-5</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keren</surname><given-names>I</given-names></name><name><surname>Shah</surname><given-names>D</given-names></name><name><surname>Spoering</surname><given-names>A</given-names></name><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2004">2004b</year><article-title>Specialized persister cells and the mechanism of multidrug tolerance in <italic>Escherichia coli</italic></article-title><source>Journal of Bacteriology</source><volume>186</volume><fpage>8172</fpage><lpage>8180</lpage><pub-id pub-id-type="doi">10.1128/JB.186.24.8172-8180.2004</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keseler</surname><given-names>IM</given-names></name><name><surname>Collado-Vides</surname><given-names>J</given-names></name><name><surname>Gama-Castro</surname><given-names>S</given-names></name><name><surname>Ingraham</surname><given-names>J</given-names></name><name><surname>Paley</surname><given-names>S</given-names></name><name><surname>Paulsen</surname><given-names>IT</given-names></name><name><surname>Peralta-Gil</surname><given-names>M</given-names></name><name><surname>Karp</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>EcoCyc: a comprehensive database resource for <italic>Escherichia coli</italic></article-title><source>Nucleic Acids Research</source><volume>33</volume><fpage>D334</fpage><lpage>D7</lpage><pub-id pub-id-type="doi">10.1093/nar/gki108</pub-id><pub-id pub-id-type="pmid">15608210</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keseler</surname><given-names>IM</given-names></name><name><surname>Collado-Vides</surname><given-names>J</given-names></name><name><surname>Santos-Zavaleta</surname><given-names>A</given-names></name><name><surname>Peralta-Gil</surname><given-names>M</given-names></name><name><surname>Gama-Castro</surname><given-names>S</given-names></name><name><surname>MuÃ±iz-Rascado</surname><given-names>L</given-names></name><name><surname>Bonavides-Martinez</surname><given-names>C</given-names></name><name><surname>Paley</surname><given-names>S</given-names></name><name><surname>Krummenacker</surname><given-names>M</given-names></name><name><surname>Altman</surname><given-names>T</given-names></name><name><surname>Kaipa</surname><given-names>P</given-names></name><name><surname>Spaulding</surname><given-names>A</given-names></name><name><surname>Pacheco</surname><given-names>J</given-names></name><name><surname>Latendresse</surname><given-names>M</given-names></name><name><surname>Fulcher</surname><given-names>C</given-names></name><name><surname>Sarker</surname><given-names>M</given-names></name><name><surname>Shearer</surname><given-names>AG</given-names></name><name><surname>Mackie</surname><given-names>A</given-names></name><name><surname>Paulsen</surname><given-names>I</given-names></name><name><surname>Gunsalus</surname><given-names>RP</given-names></name><name><surname>Karp</surname><given-names>PD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>EcoCyc: a comprehensive database of <italic>Escherichia coli</italic> biology</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>D583</fpage><lpage>D90</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1143</pub-id><pub-id pub-id-type="pmid">21097882</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Cho</surname><given-names>DH</given-names></name><name><surname>Heo</surname><given-names>P</given-names></name><name><surname>Jung</surname><given-names>SC</given-names></name><name><surname>Park</surname><given-names>M</given-names></name><name><surname>Oh</surname><given-names>EJ</given-names></name><name><surname>Sung</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>PJ</given-names></name><name><surname>Lee</surname><given-names>SC</given-names></name><name><surname>Lee</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>CH</given-names></name><name><surname>Shin</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>YS</given-names></name><name><surname>Kweon</surname><given-names>DH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fumarate-mediated persistence of <italic>Escherichia coli</italic> against antibiotics</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>60</volume><fpage>2232</fpage><lpage>2240</lpage><pub-id pub-id-type="doi">10.1128/AAC.01794-15</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolb</surname><given-names>A</given-names></name><name><surname>Busby</surname><given-names>S</given-names></name><name><surname>Buc</surname><given-names>H</given-names></name><name><surname>Garges</surname><given-names>S</given-names></name><name><surname>Adhya</surname><given-names>S</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Transcriptional regulation by cAMP and its receptor protein</article-title><source>Annual Review of Biochemistry</source><volume>62</volume><fpage>749</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1146/annurev.bi.62.070193.003533</pub-id><pub-id pub-id-type="pmid">8394684</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levin-Reisman</surname><given-names>I</given-names></name><name><surname>Ronin</surname><given-names>I</given-names></name><name><surname>Gefen</surname><given-names>O</given-names></name><name><surname>Braniss</surname><given-names>I</given-names></name><name><surname>Shoresh</surname><given-names>N</given-names></name><name><surname>Balaban</surname><given-names>NQ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Antibiotic tolerance facilitates the evolution of resistance</article-title><source>Science</source><volume>355</volume><fpage>826</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1126/science.aaj2191</pub-id><pub-id pub-id-type="pmid">28183996</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Persister cells</article-title><source>Annual Review of Microbiology</source><volume>64</volume><fpage>357</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1146/annurev.micro.112408.134306</pub-id><pub-id pub-id-type="pmid">20528688</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>JY</given-names></name><name><surname>Gao</surname><given-names>S</given-names></name><name><surname>Bai</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>Intracellular ATP concentration is a key regulator of bacterial cell fate</article-title><source>Journal of Bacteriology</source><volume>206</volume><elocation-id>e0020824</elocation-id><pub-id pub-id-type="doi">10.1128/jb.00208-24</pub-id><pub-id pub-id-type="pmid">39530704</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Pang</surname><given-names>Z</given-names></name><name><surname>Xia</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Comprehensive investigation of pathway enrichment methods for functional interpretation of LCâMS global metabolomics data</article-title><source>Briefings in Bioinformatics</source><volume>24</volume><elocation-id>bbac553</elocation-id><pub-id pub-id-type="doi">10.1093/bib/bbac553</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luidalepp</surname><given-names>H</given-names></name><name><surname>JÃµers</surname><given-names>A</given-names></name><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Tenson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Age of inoculum strongly influences persister frequency and can mask effects of mutations implicated in altered persistence</article-title><source>Journal of Bacteriology</source><volume>193</volume><fpage>3598</fpage><lpage>3605</lpage><pub-id pub-id-type="doi">10.1128/JB.00085-11</pub-id><pub-id pub-id-type="pmid">21602347</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>C</given-names></name><name><surname>Sim</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Xing</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in <italic>Escherichia coli</italic></article-title><source>FEMS Microbiology Letters</source><volume>303</volume><fpage>33</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1111/j.1574-6968.2009.01857.x</pub-id><pub-id pub-id-type="pmid">20041955</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majerfeld</surname><given-names>IH</given-names></name><name><surname>Miller</surname><given-names>D</given-names></name><name><surname>Spitz</surname><given-names>E</given-names></name><name><surname>Rickenberg</surname><given-names>HV</given-names></name></person-group><year iso-8601-date="1981">1981</year><article-title>Regulation of the synthesis of adenylate cyclase in <italic>Escherichia coli</italic> by the cAMP -- cAMP receptor protein complex</article-title><source>Molecular &amp; General Genetics</source><volume>181</volume><fpage>470</fpage><lpage>475</lpage><pub-id pub-id-type="doi">10.1007/BF00428738</pub-id><pub-id pub-id-type="pmid">6267421</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manuse</surname><given-names>S</given-names></name><name><surname>Shan</surname><given-names>Y</given-names></name><name><surname>Canas-Duarte</surname><given-names>SJ</given-names></name><name><surname>Bakshi</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>WS</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Paulsson</surname><given-names>J</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Bacterial persisters are a stochastically formed subpopulation of low-energy cells</article-title><source>PLOS Biology</source><volume>19</volume><elocation-id>e3001194</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3001194</pub-id><pub-id pub-id-type="pmid">33872303</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michiels</surname><given-names>JE</given-names></name><name><surname>Van den Bergh</surname><given-names>B</given-names></name><name><surname>Verstraeten</surname><given-names>N</given-names></name><name><surname>Michiels</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Molecular mechanisms and clinical implications of bacterial persistence</article-title><source>Drug Resistance Updates</source><volume>29</volume><fpage>76</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.drup.2016.10.002</pub-id><pub-id pub-id-type="pmid">27912845</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohiuddin</surname><given-names>SG</given-names></name><name><surname>Hoang</surname><given-names>T</given-names></name><name><surname>Saba</surname><given-names>A</given-names></name><name><surname>Karki</surname><given-names>P</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Identifying metabolic inhibitors to reduce bacterial persistence</article-title><source>Frontiers in Microbiology</source><volume>11</volume><elocation-id>472</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2020.00472</pub-id><pub-id pub-id-type="pmid">32292393</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohiuddin</surname><given-names>SG</given-names></name><name><surname>Kavousi</surname><given-names>P</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2020">2020b</year><article-title>Flow-cytometry analysis reveals persister resuscitation characteristics</article-title><source>BMC Microbiology</source><volume>20</volume><elocation-id>202</elocation-id><pub-id pub-id-type="doi">10.1186/s12866-020-01888-3</pub-id><pub-id pub-id-type="pmid">32640993</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohiuddin</surname><given-names>SG</given-names></name><name><surname>Nguyen</surname><given-names>TV</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Pleiotropic actions of phenothiazine drugs are detrimental to Gram-negative bacterial persister cells</article-title><source>Communications Biology</source><volume>5</volume><elocation-id>217</elocation-id><pub-id pub-id-type="doi">10.1038/s42003-022-03172-8</pub-id><pub-id pub-id-type="pmid">35264714</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mok</surname><given-names>WWK</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Impacts of global transcriptional regulators on persister metabolism</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>59</volume><fpage>2713</fpage><lpage>2719</lpage><pub-id pub-id-type="doi">10.1128/AAC.04908-14</pub-id><pub-id pub-id-type="pmid">25712354</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mok</surname><given-names>WWK</given-names></name><name><surname>Park</surname><given-names>JO</given-names></name><name><surname>Rabinowitz</surname><given-names>JD</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>RNA futile cycling in model persisters derived from MazF accumulation</article-title><source>mBio</source><volume>6</volume><elocation-id>e01588-15</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01588-15</pub-id><pub-id pub-id-type="pmid">26578677</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molina-Quiroz</surname><given-names>RC</given-names></name><name><surname>Silva-Valenzuela</surname><given-names>C</given-names></name><name><surname>Brewster</surname><given-names>J</given-names></name><name><surname>Castro-Nallar</surname><given-names>E</given-names></name><name><surname>Levy</surname><given-names>SB</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Cyclic AMP Regulates bacterial persistence through repression of the oxidative stress response and SOS-dependent DNA repair in uropathogenic <italic>Escherichia coli</italic></article-title><source>mBio</source><volume>9</volume><elocation-id>14417</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.02144-17</pub-id><pub-id pub-id-type="pmid">29317513</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname><given-names>CJL</given-names></name><name><surname>Ikuta</surname><given-names>KS</given-names></name><name><surname>Sharara</surname><given-names>F</given-names></name><name><surname>Swetschinski</surname><given-names>L</given-names></name><name><surname>Robles Aguilar</surname><given-names>G</given-names></name><name><surname>Gray</surname><given-names>A</given-names></name><name><surname>Han</surname><given-names>C</given-names></name><name><surname>Bisignano</surname><given-names>C</given-names></name><name><surname>Rao</surname><given-names>P</given-names></name><name><surname>Wool</surname><given-names>E</given-names></name><name><surname>Johnson</surname><given-names>SC</given-names></name><name><surname>Browne</surname><given-names>AJ</given-names></name><name><surname>Chipeta</surname><given-names>MG</given-names></name><name><surname>Fell</surname><given-names>F</given-names></name><name><surname>Hackett</surname><given-names>S</given-names></name><name><surname>Haines-Woodhouse</surname><given-names>G</given-names></name><name><surname>Kashef Hamadani</surname><given-names>BH</given-names></name><name><surname>Kumaran</surname><given-names>EAP</given-names></name><name><surname>McManigal</surname><given-names>B</given-names></name><name><surname>Naghavi</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title><source>Lancet</source><volume>399</volume><fpage>629</fpage><lpage>655</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id><pub-id pub-id-type="pmid">35065702</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Opalek</surname><given-names>M</given-names></name><name><surname>Smug</surname><given-names>BJ</given-names></name><name><surname>Wloch-Salamon</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>How to determine microbial lag phase duration?</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2022.11.16.516631</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orman</surname><given-names>MA</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2013">2013a</year><article-title>Dormancy is not necessary or sufficient for bacterial persistence</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>3230</fpage><lpage>3239</lpage><pub-id pub-id-type="doi">10.1128/AAC.00243-13</pub-id><pub-id pub-id-type="pmid">23629720</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orman</surname><given-names>MA</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2013">2013b</year><article-title>Establishment of a method to rapidly assay bacterial persister metabolism</article-title><source>Antimicrobial Agents and Chemotherapy</source><volume>57</volume><fpage>4398</fpage><lpage>4409</lpage><pub-id pub-id-type="doi">10.1128/AAC.00372-13</pub-id><pub-id pub-id-type="pmid">23817376</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orman</surname><given-names>MA</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Inhibition of stationary phase respiration impairs persister formation in <italic>E. coli</italic></article-title><source>Nature Communications</source><volume>6</volume><elocation-id>7983</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms8983</pub-id><pub-id pub-id-type="pmid">26246187</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pandey</surname><given-names>S</given-names></name><name><surname>Sahukhal</surname><given-names>GS</given-names></name><name><surname>Elasri</surname><given-names>MO</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The <italic>msaABCR</italic> operon regulates persister formation by modulating energy metabolism in <italic>Staphylococcus aureus</italic></article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>657753</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.657753</pub-id><pub-id pub-id-type="pmid">33936014</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>YH</given-names></name><name><surname>Lee</surname><given-names>BR</given-names></name><name><surname>Seok</surname><given-names>YJ</given-names></name><name><surname>Peterkofsky</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>In vitro reconstitution of catabolite repression in <italic>Escherichia coli</italic></article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>6448</fpage><lpage>6454</lpage><pub-id pub-id-type="doi">10.1074/jbc.M512672200</pub-id><pub-id pub-id-type="pmid">16407219</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parsons</surname><given-names>JB</given-names></name><name><surname>Sidders</surname><given-names>AE</given-names></name><name><surname>Velez</surname><given-names>AZ</given-names></name><name><surname>Hanson</surname><given-names>BM</given-names></name><name><surname>Angeles-Solano</surname><given-names>M</given-names></name><name><surname>Ruffin</surname><given-names>F</given-names></name><name><surname>Rowe</surname><given-names>SE</given-names></name><name><surname>Arias</surname><given-names>CA</given-names></name><name><surname>Fowler</surname><given-names>VG</given-names></name><name><surname>Thaden</surname><given-names>JT</given-names></name><name><surname>Conlon</surname><given-names>BP</given-names></name></person-group><year iso-8601-date="2024">2024</year><article-title>In-patient evolution of a high-persister <italic>Escherichia coli</italic> strain with reduced in vivo antibiotic susceptibility</article-title><source>PNAS</source><volume>121</volume><elocation-id>e2314514121</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2314514121</pub-id><pub-id pub-id-type="pmid">38190524</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pastan</surname><given-names>I</given-names></name><name><surname>Perlman</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1970">1970</year><article-title>Cyclic adenosine monophosphate in bacteria: In many bacteria the synthesis of inducible enzymes requires this cyclic nucleotide</article-title><source>Science</source><volume>169</volume><fpage>339</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1126/science.169.3943.339</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porporato</surname><given-names>PE</given-names></name><name><surname>Filigheddu</surname><given-names>N</given-names></name><name><surname>Pedro</surname><given-names>JMBS</given-names></name><name><surname>Kroemer</surname><given-names>G</given-names></name><name><surname>Galluzzi</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mitochondrial metabolism and cancer</article-title><source>Cell Research</source><volume>28</volume><fpage>265</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.1038/cr.2017.155</pub-id><pub-id pub-id-type="pmid">29219147</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prax</surname><given-names>M</given-names></name><name><surname>Bertram</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Metabolic aspects of bacterial persisters</article-title><source>Frontiers in Cellular and Infection Microbiology</source><volume>4</volume><elocation-id>148</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2014.00148</pub-id><pub-id pub-id-type="pmid">25374846</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Radzikowski</surname><given-names>JL</given-names></name><name><surname>Vedelaar</surname><given-names>S</given-names></name><name><surname>Siegel</surname><given-names>D</given-names></name><name><surname>Ortega</surname><given-names>ÃD</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Heinemann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Bacterial persistence is an active ÏS stress response to metabolic flux limitation</article-title><source>Molecular Systems Biology</source><volume>12</volume><elocation-id>882</elocation-id><pub-id pub-id-type="doi">10.15252/msb.20166998</pub-id><pub-id pub-id-type="pmid">27655400</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roostalu</surname><given-names>J</given-names></name><name><surname>JÃµers</surname><given-names>A</given-names></name><name><surname>Luidalepp</surname><given-names>H</given-names></name><name><surname>Kaldalu</surname><given-names>N</given-names></name><name><surname>Tenson</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Cell division in <italic>Escherichia coli</italic> cultures monitored at single cell resolution</article-title><source>BMC Microbiology</source><volume>8</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/1471-2180-8-68</pub-id><pub-id pub-id-type="pmid">18430255</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>Y</given-names></name><name><surname>Lazinski</surname><given-names>D</given-names></name><name><surname>Rowe</surname><given-names>S</given-names></name><name><surname>Camilli</surname><given-names>A</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Genetic basis of persister tolerance to aminoglycosides in <italic>Escherichia coli</italic></article-title><source>mBio</source><volume>6</volume><elocation-id>e00078-15</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.00078-15</pub-id><pub-id pub-id-type="pmid">25852159</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Shiraliyev</surname><given-names>R</given-names></name><name><surname>Orman</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2023.12.20.572673</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spoering</surname><given-names>AL</given-names></name><name><surname>Vulic</surname><given-names>M</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>GlpD and PlsB participate in persister cell formation in <italic>Escherichia coli</italic></article-title><source>Journal of Bacteriology</source><volume>188</volume><fpage>5136</fpage><lpage>5144</lpage><pub-id pub-id-type="doi">10.1128/JB.00369-06</pub-id><pub-id pub-id-type="pmid">16816185</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>JE</given-names></name><name><surname>Lam</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Proteomic investigation of tolerant <italic>Escherichia coli</italic> populations from cyclic antibiotic treatment</article-title><source>Journal of Proteome Research</source><volume>19</volume><fpage>900</fpage><lpage>913</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.9b00687</pub-id><pub-id pub-id-type="pmid">31920087</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Nastou</surname><given-names>KC</given-names></name><name><surname>Lyon</surname><given-names>D</given-names></name><name><surname>Kirsch</surname><given-names>R</given-names></name><name><surname>Pyysalo</surname><given-names>S</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Legeay</surname><given-names>M</given-names></name><name><surname>Fang</surname><given-names>T</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets</article-title><source>Nucleic Acids Research</source><volume>49</volume><fpage>D605</fpage><lpage>D612</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa1074</pub-id><pub-id pub-id-type="pmid">33237311</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szklarczyk</surname><given-names>D</given-names></name><name><surname>Kirsch</surname><given-names>R</given-names></name><name><surname>Koutrouli</surname><given-names>M</given-names></name><name><surname>Nastou</surname><given-names>K</given-names></name><name><surname>Mehryary</surname><given-names>F</given-names></name><name><surname>Hachilif</surname><given-names>R</given-names></name><name><surname>Gable</surname><given-names>AL</given-names></name><name><surname>Fang</surname><given-names>T</given-names></name><name><surname>Doncheva</surname><given-names>NT</given-names></name><name><surname>Pyysalo</surname><given-names>S</given-names></name><name><surname>Bork</surname><given-names>P</given-names></name><name><surname>Jensen</surname><given-names>LJ</given-names></name><name><surname>von Mering</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest</article-title><source>Nucleic Acids Research</source><volume>51</volume><fpage>D638</fpage><lpage>D646</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac1000</pub-id><pub-id pub-id-type="pmid">36370105</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taber</surname><given-names>HW</given-names></name><name><surname>Mueller</surname><given-names>JP</given-names></name><name><surname>Miller</surname><given-names>PF</given-names></name><name><surname>Arrow</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="1987">1987</year><article-title>Bacterial uptake of aminoglycoside antibiotics</article-title><source>Microbiological Reviews</source><volume>51</volume><fpage>439</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1128/mr.51.4.439-457.1987</pub-id><pub-id pub-id-type="pmid">3325794</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Tirabassi</surname><given-names>R</given-names></name><name><surname>Bio</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><source>Foundations of Molecular Cloning-Past, Present and Future</source><publisher-name>NEB, New England Bio Labs Inc, Www. Neb. Com/Tools-and-Resources/Featurearticles/Foundations-of-Molecular-Cloning-Past-Present-and-Future</publisher-name></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasan</surname><given-names>K</given-names></name><name><surname>Werner</surname><given-names>M</given-names></name><name><surname>Chandel</surname><given-names>NS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mitochondrial metabolism as a target for cancer therapy</article-title><source>Cell Metabolism</source><volume>32</volume><fpage>341</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2020.06.019</pub-id><pub-id pub-id-type="pmid">32668195</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vulin</surname><given-names>C</given-names></name><name><surname>Leimer</surname><given-names>N</given-names></name><name><surname>Huemer</surname><given-names>M</given-names></name><name><surname>Ackermann</surname><given-names>M</given-names></name><name><surname>Zinkernagel</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prolonged bacterial lag time results in small colony variants that represent a sub-population of persisters</article-title><source>Nature Communications</source><volume>9</volume><elocation-id>4074</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-06527-0</pub-id><pub-id pub-id-type="pmid">30287875</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wakamoto</surname><given-names>Y</given-names></name><name><surname>Dhar</surname><given-names>N</given-names></name><name><surname>Chait</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>K</given-names></name><name><surname>Signorino-Gelo</surname><given-names>F</given-names></name><name><surname>Leibler</surname><given-names>S</given-names></name><name><surname>McKinney</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Dynamic persistence of antibiotic-stressed mycobacteria</article-title><source>Science</source><volume>339</volume><fpage>91</fpage><lpage>95</lpage><pub-id pub-id-type="doi">10.1126/science.1229858</pub-id><pub-id pub-id-type="pmid">23288538</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Bojer</surname><given-names>MS</given-names></name><name><surname>George</surname><given-names>SE</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Jensen</surname><given-names>PR</given-names></name><name><surname>Wolz</surname><given-names>C</given-names></name><name><surname>Ingmer</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Inactivation of TCA cycle enhances <italic>Staphylococcus aureus</italic> persister cell formation in stationary phase</article-title><source>Scientific Reports</source><volume>8</volume><elocation-id>10849</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-018-29123-0</pub-id><pub-id pub-id-type="pmid">30022089</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warburg</surname><given-names>O</given-names></name></person-group><year iso-8601-date="1925">1925</year><article-title>The metabolism of carcinoma cells</article-title><source>The Journal of Cancer Research</source><volume>9</volume><fpage>148</fpage><lpage>163</lpage><pub-id pub-id-type="doi">10.1158/jcr.1925.148</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windels</surname><given-names>EM</given-names></name><name><surname>Michiels</surname><given-names>JE</given-names></name><name><surname>Fauvart</surname><given-names>M</given-names></name><name><surname>Wenseleers</surname><given-names>T</given-names></name><name><surname>Van den Bergh</surname><given-names>B</given-names></name><name><surname>Michiels</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Bacterial persistence promotes the evolution of antibiotic resistance by increasing survival and mutation rates</article-title><source>The ISME Journal</source><volume>13</volume><fpage>1239</fpage><lpage>1251</lpage><pub-id pub-id-type="doi">10.1038/s41396-019-0344-9</pub-id><pub-id pub-id-type="pmid">30647458</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>R</given-names></name><name><surname>Song</surname><given-names>S</given-names></name><name><surname>Benedik</surname><given-names>MJ</given-names></name><name><surname>Wood</surname><given-names>TK</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Persister cells resuscitate using membrane sensors that activate chemotaxis, Lower cAMP levels, and revive ribosomes</article-title><source>iScience</source><volume>23</volume><elocation-id>100792</elocation-id><pub-id pub-id-type="doi">10.1016/j.isci.2019.100792</pub-id><pub-id pub-id-type="pmid">31926430</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Chang</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Regrowth-delay body as a bacterial subcellular structure marking multidrug-tolerant persisters</article-title><source>Cell Discovery</source><volume>5</volume><elocation-id>8</elocation-id><pub-id pub-id-type="doi">10.1038/s41421-019-0080-3</pub-id><pub-id pub-id-type="pmid">30675381</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>KK</given-names></name></person-group><year iso-8601-date="1974">1974</year><article-title>The two-sample trimmed <italic>t</italic> for unequal population variances</article-title><source>Biometrika</source><volume>61</volume><fpage>165</fpage><lpage>170</lpage><pub-id pub-id-type="doi">10.1093/biomet/61.1.165</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zalis</surname><given-names>EA</given-names></name><name><surname>Nuxoll</surname><given-names>AS</given-names></name><name><surname>Manuse</surname><given-names>S</given-names></name><name><surname>Clair</surname><given-names>G</given-names></name><name><surname>Radlinski</surname><given-names>LC</given-names></name><name><surname>Conlon</surname><given-names>BP</given-names></name><name><surname>Adkins</surname><given-names>J</given-names></name><name><surname>Lewis</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Stochastic variation in expression of the tricarboxylic acid cycle produces persister cells</article-title><source>mBio</source><volume>10</volume><elocation-id>e01930-19</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01930-19</pub-id><pub-id pub-id-type="pmid">31530676</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaslaver</surname><given-names>A</given-names></name><name><surname>Bren</surname><given-names>A</given-names></name><name><surname>Ronen</surname><given-names>M</given-names></name><name><surname>Itzkovitz</surname><given-names>S</given-names></name><name><surname>Kikoin</surname><given-names>I</given-names></name><name><surname>Shavit</surname><given-names>S</given-names></name><name><surname>Liebermeister</surname><given-names>W</given-names></name><name><surname>Surette</surname><given-names>MG</given-names></name><name><surname>Alon</surname><given-names>U</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>A comprehensive library of fluorescent transcriptional reporters for <italic>Escherichia coli</italic></article-title><source>Nature Methods</source><volume>3</volume><fpage>623</fpage><lpage>628</lpage><pub-id pub-id-type="doi">10.1038/nmeth895</pub-id><pub-id pub-id-type="pmid">16862137</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Di</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Havlin</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022a</year><article-title>Impactful scientists have higher tendency to involve collaborators in new topics</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2207436119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2207436119</pub-id><pub-id pub-id-type="pmid">35939670</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>J</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>N</given-names></name><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Hong</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Niu</surname><given-names>J</given-names></name><name><surname>Drlica</surname><given-names>K</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2022">2022b</year><article-title>A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade</article-title><source>PNAS</source><volume>119</volume><elocation-id>e2118566119</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2118566119</pub-id><pub-id pub-id-type="pmid">35648826</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>EJ</given-names></name><name><surname>Stokes</surname><given-names>JM</given-names></name><name><surname>Collins</surname><given-names>JJ</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Eradicating bacterial persisters with combinations of strongly and weakly metabolism-dependent antibiotics</article-title><source>Cell Chemical Biology</source><volume>27</volume><fpage>1544</fpage><lpage>1552</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2020.08.015</pub-id><pub-id pub-id-type="pmid">32916087</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1âkey resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Strain, strain background <italic>(Escherichia coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Wild Type</td><td align="left" valign="bottom">Gift from Dr. Mark P. Brynildsen</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/><italic>hipA7</italic></td><td align="left" valign="bottom">Gift from Dr. Mark P. Brynildsen</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/><italic>hipA7</italic>Î<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/><italic>hipA7</italic>Î<italic>cyaA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Wild Type</td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC5042</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>MO</td><td align="left" valign="bottom">Gift from Dr. Mark P. Brynildsen</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>MO Î<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>MO Î<italic>cyaA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>cyaA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>sucA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>lpd</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>sucC</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>sdhA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>gltA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>aceE</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>tktB</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>mdh</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>nuoI</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>nuoM</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>atpA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>atpB</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>atpC</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>atpD</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>frdC</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>pgi</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>zwf</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>talA</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>acnB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sucA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sucB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sucC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sdhD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sdhC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sdhB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sdhA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>aceF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>talB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>cyoA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>cyoB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>cyoC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>cyoD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>acnA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>icd</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fumA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fumB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fumC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>mdh</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pgi</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pfkA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>tpiA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>gpmM</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ppsA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pykF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pykA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>maeB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pck</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>rpiB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>rpe</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>tktB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>talA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>zwf</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>gnd</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ppc</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>frdA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>frdB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>frdC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>frdD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>adhE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pflB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>aceB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>aceA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>glcB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoH</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoJ</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoK</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoL</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoM</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoN</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoI</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>appC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>appB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>gltA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>lpd</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fbp</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>aceE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>tktA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pta</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ackA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ldhA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>dld</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>cydB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>poxB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>glpX</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ybhA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>cydX</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fumE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>yggF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ccp</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>yieF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>wrbA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdhF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nrfD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nrfC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nrfA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>putA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>dmsC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>torC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>torA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hyaA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hyaB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hyaC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>kefF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>narV</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>narI</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>kduI</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>eutE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hycE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hycG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>edd</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>eda</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdnG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdnI</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>glpD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>glpA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>glpB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>glpC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hybO</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hybC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>narY</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>narZ</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>napG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>napH</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>napA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>purT</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdoG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdoI</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpF</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpH</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>phoA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>adhP</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>eutD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>dmsA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hybB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>napB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpI</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>maeA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>pfkB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fbaB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>rpiA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fumD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>sucD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdnH</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>dmsB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>ndh</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>narG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>narH</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>tdcE</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hycB</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hycC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hycD</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>fdoH</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>hybA</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>nuoC</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 BW25113<break/>Î<italic>atpG</italic></td><td align="left" valign="bottom">Keio collection</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom"><italic>pMSs201 (kan<sup>R</sup>)</italic></td><td align="left" valign="bottom">Dharmacon Promoter Library</td><td align="left" valign="bottom">Catalog # OEC4988</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUA66-EV (empty vector)</td><td align="left" valign="bottom">Gift from Dr. Mark P. Brynildsen</td><td align="left" valign="bottom"/><td align="left" valign="bottom">A DNA fragment including <italic>T5</italic> promoter, <italic>Kan<sup>R</sup></italic> gene, pUA66 origin of replication and <italic>lacI<sup>q</sup></italic> was amplified from the pUA66-<italic>gfp</italic> plasmid with primers having BspHI cut sites. The amplified DNA fragment was digested with BspHI, and then self-ligated to obtain the modified pUA66-EV that does not have the <italic>gfp</italic> gene.</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pUA66-<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom">The <italic>crp</italic> gene with its promoter was amplified from the genomic DNA of <italic>E. coli</italic>, using forward and reverse primers with BglII and ScaI restriction enzyme cut sites, respectively. The pUA66-<italic>gfp</italic> plasmid was double digested with BglII and ScaI to remove T5 promoter region and <italic>gfp</italic> gene. Then, the digested <italic>crp</italic> gene with its promoter and plasmid were ligated to generate pUA66-<italic>crp</italic>.</td></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>pMSs201 P<italic><sub>sdhABCD</sub>-gfp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>crp</italic> pMSs201 P<italic><sub>sdhABCD</sub>-gfp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>cyaA</italic> pMSs201 P<italic><sub>sdhABCD</sub>-gfp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>pMSs201 P<italic><sub>cyaA</sub>-gfp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>crp</italic> pMSs201 P<italic><sub>cyaA</sub>-gfp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>cyaA</italic> pMSs201 P<italic><sub>cyaA</sub>-gfp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>crp</italic> pUA66-EV</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Strain, strain background <italic>(E. coli)</italic></td><td align="left" valign="bottom">K-12 MG1655<break/>Î<italic>crp</italic> pUA66-<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism (version 10.3.0)</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/">http://www.graphpad.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">FlowJo (version 10.8.1)</td><td align="left" valign="bottom">Becton, Dickinson &amp; Company</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_008520">SCR_008520</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.flowjo.com/">https://www.flowjo.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MATLAB (version R2020b)</td><td align="left" valign="bottom">MathWorks</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID:SCR_001622">SCR_001622</ext-link></td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.mathworks.com/">https://www.mathworks.com/</ext-link></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>crp</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TCTGGCTCTGGAGAAAGCTTATAACAGAGGATAACCGCGCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>crp</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">AAAATGGCGCGCTACCAGGTAACGCGCCACTCCGACGGGATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>cyaA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GAATCACAGTCATGACGGGTAGCAAATCAGGCGATACGTCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>cyaA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">AGATTGCATGCCGGATAAGCCTCGCTTTCCGGCACGTTCATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>sucA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">ACGGCGAAGTAAGCATAAAAAAGATGCTTAAGGGATCACGGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>sucA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GGTCAGGGACCAGAATATCTACGCTACTCATTGTGTAT</named-content><break/><named-content content-type="sequence">CCTTTATTTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>lpd</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GACGGGTATGACCGCC</named-content><break/><named-content content-type="sequence">GGAGATAAATATATAGAGGTCATGGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>lpd</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCCGCTTTTTTAATTGCCGGATGTTCCGGCAAACGAAAAATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>sucC</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GGTTTAAAAGATAACGATTACTGAAGGATGGACAGAACACGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>sucC</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TGGCAGATAACCTTGGTG</named-content><break/><named-content content-type="sequence">TTTTTATCGATTAAAATGGACATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>sdhA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TTTACGTGATTTATG</named-content><break/><named-content content-type="sequence">GATTCGTTGTGGTGT</named-content><break/><named-content content-type="sequence">GGGGTGTGTGGTGTA</named-content><break/><named-content content-type="sequence">GGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>sdhA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GATAAATTGAAAACT</named-content><break/><named-content content-type="sequence">CGAGTCTCATTTTCC</named-content><break/><named-content content-type="sequence">TGTCTCCGCATTAAC</named-content><break/><named-content content-type="sequence">GGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>gltA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TAAGTTCCGGCAGTCTTACGCAATAAGGCGCTAAG</named-content><break/><named-content content-type="sequence">GAGACCTTAAGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>gltA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CCCGCCATATGAACGGCGGGTTAAAATATTTACAACTTAGCAATCAACCATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>aceE</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GGTTCCAGAAAACTCAACGTTATTAGATAGATAAGGAATAACCCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>aceE</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCCCCGATGTCCGGTACTTTGATTTCGATAGCCATTATTCTTTTACCTCTTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>mdh</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGGAGCAACATATCTTAGTTTATCAATATAATAAGGAGTTTAGGGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>mdh</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CCGGAGTCTGTGCTCCGGTTTTTTATTATCCGCTAATCAATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>nuoI</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CTGTCATTCTCTGGCAGGCGCAATAAGGGGCAATAAGACCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>nuoI</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">AGGCCACAGATATAAAAAGC</named-content><break/><named-content content-type="sequence">GAACTCCATTGCCCCTCTCCTT</named-content><break/><named-content content-type="sequence">AACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>nuoM</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TCCGGTCCTGACGGGACTTTTACAAGGAATAAAGATCGCCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>nuoM</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCAGTGCGATCAGGTTTTGTGGAGTTATTGTCATGGCGATTTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>atpA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGCCTTGCAGACGTCTTGCAGTCTTAAGGGGACTGGAGCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>atpA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TCAATGCCTTGCGGCCTGCCCTAAGGCAAGCCGCCAGACGTTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>atpB</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TGGCACCGGCTGTAATTAA</named-content><break/><named-content content-type="sequence">CAACAAAGGGTAAAAGGCATCGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>atpB</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CTCCAGTTTGTTTCAGTTAAAACGTAGTAGTGTTGGTAAATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>atpC</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GGAAAAAGCCAAAAAACTTTAACGCCTTAATCGGAGGGTGATGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>atpC</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCCTGTTTCCAGACTGGCTTTTGTGCTTTTCAAGCCGGTGTTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>atpD</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CCGCCGCGGTTTAAACAGGTT</named-content><break/><named-content content-type="sequence">ATTTCGTAGAGGATTTAAGGTGTA</named-content><break/><named-content content-type="sequence">GGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>atpD</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">AGGTGGTAAGTCATTGCCATAT</named-content><break/><named-content content-type="sequence">CACCCTCCGATTAAGGCGTTAAC</named-content><break/><named-content content-type="sequence">GGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>frdC</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">TTTCTTATCGCGACCCTGAAACCACGCTAAGGAGTGCAACGTG</named-content><break/><named-content content-type="sequence">TAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>frdC</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GTCAGAACGCTTTGGATTTGG</named-content><break/><named-content content-type="sequence">ATTAATCATCTCAGGCTCCTTAAC</named-content><break/><named-content content-type="sequence">GGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>pgi</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCTACAATCTTCCAAAGTCACA</named-content><break/><named-content content-type="sequence">ATTCTCAAAATCAGAAGAGTATTGC</named-content><break/><named-content content-type="sequence">TAGTGTAGGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>pgi</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGGCGTGAACGCCTTATCC</named-content><break/><named-content content-type="sequence">GGCCTACATATCGACGATGATTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>zwf</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CTGGCTTAAGTACCGGGTTAG</named-content><break/><named-content content-type="sequence">TTAACTTAAGGAGAATGACGTGTA</named-content><break/><named-content content-type="sequence">GGCTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>zwf</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGCAAGATCATGTTACC</named-content><break/><named-content content-type="sequence">GGTAAAATAACCATAAAGGA</named-content><break/><named-content content-type="sequence">TAAGCGCAGATATTAACGGC</named-content><break/><named-content content-type="sequence">TGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>tktB</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">CTTCTTGCCGCCAAACT</named-content><break/><named-content content-type="sequence">ATAAACCAGCCACGGAGTG</named-content><break/><named-content content-type="sequence">TTATGTGTAGGCTGGAGCTG</named-content><break/><named-content content-type="sequence">CTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>tktB</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GTCAGCGTCGCATCCGGCAA</named-content><break/><named-content content-type="sequence">TCAGCATCCGGCAATCACCATTA</named-content><break/><named-content content-type="sequence">ACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â)<break/>Î<italic>talA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom">â<break/><named-content content-type="sequence">CGCACTCATCTAACACTTTACT</named-content><break/><named-content content-type="sequence">TTTCAAGGAGTATTTCCTGTGTAGG</named-content><break/><named-content content-type="sequence">CTGGAGCTGCTTC</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â)<break/>Î<italic>talA</italic>::KAN(R)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GGCAAGGTCTTTTCGGGAC</named-content><break/><named-content content-type="sequence">ATATAACACTCCGTGGCTGGT</named-content><break/><named-content content-type="sequence">TTAACGGCTGACATGGGAAT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Forward Primer (5â to 3â) pUA66-<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGCTCAGATCTTGATC</named-content><break/><named-content content-type="sequence">CGAAAGCTATGCTAAAACAGT</named-content></td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">Reverse Primer (5â to 3â) pUA66-<italic>crp</italic></td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">Integrated DNA Technologies, Inc.</td><td align="left" valign="bottom"><named-content content-type="sequence">GCGCTCAGTACT</named-content>ttaAC<break/>GAGTGCCGTAAACGA</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99735.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kornmann</surname><given-names>Benoit</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>University of Oxford</institution><country>United Kingdom</country></aff></contrib></contrib-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group></front-stub><body><p>The study reports an <bold>important</bold> finding on the role of the global metabolic regulator Crp/cAMP in the formation of antibiotic persister <italic>Escherichia coli</italic>. The evidence supporting the claims is <bold>solid</bold> including metabolomic analysis and characterization of many mutant strains.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99735.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>The authors set out to understand the role played by a key global metabolic regulator called Crp/cAMP in the formation of persister <italic>Escherichia coli</italic> that survive antibiotic treatment without acquiring genetic mutations.</p><p>In order to achieve this aim, the authors employ an interdisciplinary approach integrating standard microbiology assays with cutting-edge genomic, metabolomic and proteomics screening.</p><p>The data presented by the authors convincingly demonstrate that the deletion of two key genes that are part of the Crp/cAMP complex (i.e. crp and cyaA) leads to a significant decrease in the number of <italic>E. coli</italic>.</p><p>The authors have carried out additional experiments to further validate this point by using the well characterised hipA7 <italic>E. coli</italic> mutant.</p><p>The data presented also demonstrate that deletion of the crp gene leads to an overall decrease in energy metabolism and an overall increase in anabolic metabolism at the population level. The deletion of cyaA has an opposite effect on cAMP concentration compared to crp deletion, the authors presented a possible hypotheses but did not test it.</p><p>The authors have now explicitly acknowledged in their discussion that the data presented in this study are obtained at the whole population level rather than at the level of the persister subpopulation and therefore should be considered with caution.</p><p>Finally, the authors convincingly show that the persisters they investigated are non-growing and have a higher redox activity and that the deletion of key genes involved in energy metabolism leads to a decrease in the number of persisters.</p><p>These data will be important for future investigations on the biochemical mechanisms that allow bacteria to adapt to stressors such as nutrient depletion or exposure to antibiotics. As such this work will likely have an impact in a variety of fields such as bacterial biochemistry, antimicrobial resistance research and environmental microbiology.</p><p>Strengths:</p><p>Interdisciplinary approach.</p><p>Excellent use of replication and ensuring reproducibility.</p><p>Excellent understanding and presentation of the biochemical mechanisms underpinning bacterial physiology via an integrated genomic, metabolomic and proteomic screening.</p><p>Weaknesses:</p><p>There is no tested mechanisms explaining why the deletion of cyaA has an opposite effect on cAMP concentration compared to crp deletion.</p><p>Metabolomics, proteomics and metabolic activity data are obtained at the whole population level rather than at the level of the persister sub-population.</p></body></sub-article><sub-article article-type="author-comment" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99735.3.sa2</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ngo</surname><given-names>Han G</given-names></name><role specific-use="author">Author</role><aff><institution>University of Houston</institution><addr-line><named-content content-type="city">HOUSTON</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Mohiuddin</surname><given-names>Sayed Golam</given-names></name><role specific-use="author">Author</role><aff><institution>University of Houston</institution><addr-line><named-content content-type="city">HOUSTON</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Ananda</surname><given-names>Aina</given-names></name><role specific-use="author">Author</role><aff><institution>Monmouth University</institution><addr-line><named-content content-type="city">West Long Branch</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Orman</surname><given-names>Mehmet</given-names></name><role specific-use="author">Author</role><aff><institution>University of Houston</institution><addr-line><named-content content-type="city">Houston</named-content></addr-line><country>United States</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authorsâ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1:</bold></p><p>(1) Two genes from the Crp/cAMP complex (<italic>crp</italic> and <italic>cyaA</italic>) are hypothesized to be key for persistence but key metabolomics and proteomics data are obtained from only one deletion mutant in the crp gene.</p></disp-quote><p>We thank the reviewer for their thoughtful assessment of our manuscript and for providing valuable comments.</p><p>In our study, we have demonstrated that deletion of both <italic>cyaA</italic> and crp genes results in the same persistence phenotype. In a previous study, we screened knockout strains of global transcriptional regulators using the aminoglycoside (AG) potentiation assay and found that, across a panel of carbon sources, AG potentiation occurred in tolerant cells derived from most knockout strainsâexcept for Î<italic>crp</italic> and Î<italic>crp</italic> (Mok et al., 2015). This indicated that both genes are critical components of the Crp/cAMP regulatory network in persistence. Because cAMP exerts its effects when bound to its receptor protein Crp, disrupting crp alone should effectively abolish Crp/cAMP complex function (Keseler et al., 2011). Thus, we reasoned that comparing Î<italic>crp</italic> to wild-type would be sufficient to capture the key metabolic and proteomic alterations arising from Crp/cAMP perturbation. Given the substantial cost and labor intensity of untargeted metabolomics and proteomics analyses, this experimental design allowed us to extract meaningful insights while maintaining feasibility. Nonetheless, to ensure the robustness of our findings, we have conducted all subsequent validation experiments using both Î<italic>crp</italic> and Î<italic>crp</italic> strains, confirming that the observed metabolic and proteomic changes are consistent across both mutants. We have now provided a concise justification statement in the manuscript (see lines 197-200 in the current manuscript).</p><disp-quote content-type="editor-comment"><p>(2) The deletion of crp and <italic>crp</italic> have opposite effects on the concentration of cAMP, a comparison of metabolomics and proteomics data obtained using both mutants might aid in understanding this difference.</p></disp-quote><p>Although this is an interesting outcome, we have already discussed in the manuscript that it is likely due to the feedback regulation of the Crp/cAMP complex on <italic>crp</italic> expression (see Fig. 1 Keseler et al., 2011) (Aiba, 1985; Keseler et al., 2011; Majerfeld et al., 1981). Specifically, perturbation of the Crp/cAMP complex by deleting <italic>crp</italic> should enhance <italic>crp</italic> promoter (P<italic>crp</italic>) activity, leading to increased CyaA protein expression and, consequently, elevated intracellular cAMP levels. To experimentally verify this predicted feedback regulation, we utilized <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>crp</italic> strains harboring the pMSs201 plasmid, which encodes green fluorescent protein (<italic>gfp</italic>) under the control of the P<italic><sub>cyaA</sub></italic> promoter. This design allowed us to directly assess the effect of Crp/cAMP perturbation on P<italic><sub>cyaA</sub></italic> activity by quantifying <italic>gfp</italic> expression as a reporter. By comparing the mutant strains to WT, we could determine whether loss of Crp/cAMP function indeed derepresses <italic>crp</italic> expression. As expected, genetic perturbation of Crp/cAMP enhanced P<italic><sub>cyaA</sub></italic> promoter activity, resulting in increased gfp expression (Figure 1-figure supplement 2). This result supports the role of Crp/cAMP in regulating <italic>crp</italic> expression via feedback control. We have now explicitly discussed this rationale in the manuscript and included the corresponding data (see lines 410-418 and Figure 1-figure supplement 2 in the current manuscript).</p><disp-quote content-type="editor-comment"><p>(3) Metabolomics, proteomics, and metabolic activity data are obtained at the whole population level rather than at the level of the persister sub-population.</p></disp-quote><p>Performing metabolomic, proteomic, and other assays at the level of the persister subpopulation is inherently challenging in this study and across the persister research field, as it requires isolating a pure persister population. While metabolic inhibitors like rifampin and tetracycline can induce dormancy and antibiotic tolerance in the entire population (Kwan et al., 2013), these treatments generate artificially altered cell states that may not accurately reflect naturally occurring persisters. Fluorescent reporters combined with fluorescence-activated cell sorting (FACS) have been utilized to study persister cells, including in our previous studies (Amato et al., 2013; Orman &amp; Brynildsen, 2013, 2015). However, this approach only enriches for persisters rather than isolating a pure population, as persisters still constitute a small fraction of the sorted cells (Amato et al., 2013; Orman &amp; Brynildsen, 2013, 2015). Despite these limitations, our untargeted metabolomics and proteomics analyses at the whole-population level provide valuable insights into the regulatory mechanisms of the Crp/cAMP complex and its potential role in persister formation. We have rigorously examined the impact of these mechanisms on non-growing cell formation (see Figure 4 in the current manuscript) and persister levels (see Figure 5 in the current manuscript) through flow cytometry and single-gene deletion experiments. We appreciate the reviewerâs comment and have acknowledged and discussed these methodological challenges in our manuscript (see lines 397-406 in the current manuscript).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2:</bold></p><p>(1) The approaches used here are aimed at the major bacterial population, but yet the authors used the data reflecting the major population behavior to interpret the physiology of persister cells that comprise less than 1% of the major bacterial population. How they can pick up a needle from the hay without being fooled by the spill-over artifacts from the major population? Although it is probably very difficult to isolate and directly assay persister cells, firm conclusions for the type proposed by the authors cannot be firmly established without such assays. Perhaps introducing <italic>crp</italic>/crp mutation into the best example of persistence, the hipA-7 high persistence phenotype may clarify this issue to a certain extent.</p></disp-quote><p>We thank the reviewer for their thoughtful assessment of our manuscript and for providing valuable comments.</p><p>Performing metabolomics and proteomics at the level of the persister subpopulation remains a major challenge in this study and across the persister research field, as it requires isolating a pure persister population. While metabolic inhibitors like rifampin and tetracycline can induce dormancy and antibiotic tolerance in the entire population (Kwan et al., 2013), these treatments generate artificially altered cell states that may not accurately reflect naturally occurring persisters. Similarly, fluorescent reporters combined with fluorescence-activated cell sorting (FACS) have been employed to study persister cells, including in our previous studies (Amato et al., 2013; Orman &amp; Brynildsen, 2013, 2015). However, this approach only results in persister-enriched populations rather than a pure isolate, meaning that persisters still constitute a small fraction of the sorted cells (Amato et al., 2013; Orman &amp; Brynildsen, 2013, 2015). Despite these inherent limitations, our untargeted metabolomics and proteomics analyses at the whole-population level provide valuable insights into the regulatory mechanisms of the Crp/cAMP complex and its potential role in persister formation. Specifically, our data reveal clear indications that Crp/cAMP activity promotes the formation of a non-growing cell subpopulation, while its deletion reduces this effect. We have validated this observation through single-cell analyses (see Figure 4 in the current manuscript). Additionally, our data strongly suggest that energy metabolism plays a critical role in persister cell physiology, and we have rigorously tested this hypothesis using persister assays for single-gene deletions (see Figure 5 in the current manuscript).</p><p>Furthermore, in response to the reviewerâs suggestion, we introduced <italic>crp</italic> and <italic>crp</italic> deletions into the HipA-7 high-persistence mutant strain. The impact of these deletions in HipA-7 mirrored their effects in the wild-type strain (Figure 1-figure supplement 8), further supporting our conclusions. This data has been provided and discussed in the manuscript (see lines 185-189, and Figure 1-figure supplement 8 in the current manuscript).</p><p>We acknowledge the challenges in directly assaying persister cells, and we have now discussed this in the manuscript (see lines 397-406 in the current manuscript).</p><disp-quote content-type="editor-comment"><p>(2) The authors overlooked/omitted a recently published work regarding <italic>cyaA</italic> and crp (PMID: 35648826). In that work, a deficiency in <italic>cyaA</italic> or crp confers tolerance to diverse types of lethal stressors, including all lethal antimicrobials tested. How a mutation conferring pan-tolerance to the major bacterial population would lead to a less protective effect with a minor subpopulation? The authors are kind of obligated to discuss such a paradox in the context of their work because that is the most relevant literature for the present work. It is also very interesting if the <italic>cyaA</italic>/crp deficiency really has an opposing effect on tolerance and persistence. As a note, most of the conclusions from the omics studies of the present work have been reached in that overlooked literature, which addresses mechanisms of tolerance, a major rather than a minor population behavior. That supports comment #1 above. The inability of the authors to observe tolerance phenotype with the <italic>cyaA</italic> or crp mutant possibly derived from extremely high antimicrobial concentrations used in the study prevents tolerance phenotype from being observed because tolerance is sensitive to antimicrobial concentration while persistence is not.</p><p>(3) The authors overly stressed the effect of <italic>cyaA</italic>/crp on persister formation but failed to test an alternative explanation of their effect on persister waking up after antimicrobial treatment. If the <italic>cyaA</italic>/crp-derived persisters are put into deeper sleep during antimicrobial treatment than wildtype-derived persisters, a 16-h recovery growth might have underestimated viable bacteria. This is often the case especially when extremely high concentrations of antimicrobials are used in performing persister assay. Thus, at least a longer incubation time (e.g. 48 and 72h) of agar plates for persister viable count needs to be performed to test such a scenario.</p><p>(4) The rationale for using extremely high drug concentrations to perform persister assay is unclear. There are 2 issues with using extremely high drug concentrations. First, when overly high concentrations are used, drug removal becomes difficult. For example, a two-time wash will not be able to bring drug concentration from &gt; 100 x MIC to below MIC. This is especially problematic with aminoglycoside because drug removal by washing does not work well with this class of compound. Second, overly high concentrations of drug use may make killing so rapidly and severely that may mask the difference from being observed between mutants and the control wild-type strain. In such cases, you would need to kill over a wide range of drug concentrations to find the right window to show a difference. The gentamicin data in the present work is likely the case that needs to be carefully examined. The mutants and the wild-type strain have very different MICs for gentamicin, but a single absolute drug concentration rather than concentrations normalized to MIC was used. This is like to compare a 12-year-old with a 21-year-old to run a 100-meter dash, which is highly inappropriate.</p></disp-quote><p>The reviewer notes that key literature (PMID: 35648826) was overlooked, showing <italic>cyaA</italic>/crp deficiency confers broad stress toleranceâcontradicting the reported reduction in persister protection. They suggest high drug concentrations may mask tolerance, and also, longer incubation (48â72 h) and normalized drug levels based on MIC are recommended. Given that these three independent comments are interconnected, we will address them together.</p><p>We follow a rigorous washing protocol to minimize antibiotic carryover. After treatment, 1 ml of culture is centrifuged at 13,300 RPM (17,000 x g) for 3 minutes, and &gt;950 Âµl of supernatant is removed without disturbing the pellet. The pellet is resuspended in 950 Âµl PBS, diluting antibiotics &gt;20-fold. This step is repeated, resulting in a &gt;400-fold cumulative dilution. After the final wash, cells are resuspended in 100 Âµl PBS, then serially diluted and plated on antibiotic-free agar to ensure consistency and eliminate residual antibiotics. Preliminary experiments are routinely done in our laboratory to confirm the effectiveness of washing procedures. To address concerns that high antibiotic concentrations may mask phenotypic differencesâparticularly in the gentamicin assayâwe conducted additional experiments using MIC-normalized doses (5Ã, 10Ã, and the original study concentration) with six wash steps. As shown in Figure 1-figure supplement 6, all concentrations consistently reduced persister levels, supporting our original findings. While 5Ã MIC ampicillin allowed detection of persisters in mutant strains, their levels remained multiple orders of magnitude lower than in wild-type, maintaining statistical significance. These results, along with updated washing protocols, are now included in the revised manuscript (see lines 176-185 and Figure 1-figure supplement 6 in the current manuscript).</p><p>Although we standardize the incubation time of the agar plates for all conditions and strains, most strains form sufficiently large colonies within 16 hours, and longer incubation often leads to large, overlapping colonies that hinder accurate counting. We assure the reviewer that we always leave the plates in the incubator beyond the initial counting period to monitor the emergence of any new colonies. Here, we provide plate images of key strains after antibiotic treatments, demonstrating that extended incubation did not alter CFU levels, as shown in Figure 1-figure supplement 7. We have updated the relevant section in the Materials and Methods to clarify this point and included the plate images in the current manuscript (see lines 181-182 and Figure 1-figure supplement 7 in the current manuscript).</p><p>We acknowledge the significance of the study highlighted by the reviewer (Zeng et al., 2022); however, direct comparisons with our results are challenging due to substantial differences in experimental conditions, antibiotic concentrations, treatment durations, and most importantly, the <italic>E. coli</italic> strains used. The study of Zeng et al., 2022, utilized strains from the Keio collection, a commercially available <italic>E. coli</italic> BW25113 mutant library, which may contain unknown background mutations that could influence tolerance phenotypes. While we used the Keio collection for initial screening, we always validate single clean deletions in our lab strain, <italic>E. coli</italic> MG1655, to ensure robust conclusions. The observed variations in tolerance and persistence between studies can largely be attributed to these methodological differences rather than an inherent paradox. The concentrations of ampicillin (200 Âµg/mL) and ofloxacin (5 Âµg/mL) used in our assays are in line with concentrations employed in foundational persister studies (Amato &amp; Brynildsen, 2015; Cui et al., 2016; Hansen et al., 2008; Leszczynska et al., 2013; Lin et al., 2022; Orman &amp; Brynildsen, 2015; Shah et al., 2006). These levels represent &gt;10 Ã the MIC and are necessary to ensure the elimination of actively growing cells, thus enriching for persister cells that, by definition, survive high bactericidal drug exposure. Our aim is not to model pharmacokinetics per se, but to apply a standardized challenge to distinguish phenotypic persistence. Furthermore, pharmacokinetic and pharmacodynamic clinical data show that antibiotics such as ofloxacin and ampicillin can reach levels far exceeding 10Ã MIC for extended periods in patients (OFLOXACIN, 2019; Soto et al., 2014).</p><p>To assess how <italic>cyaA</italic> and crp deletions affect antibiotic responses under conditions similar to those used by Zeng et al. (Zeng et al., 2022) âspecifically, exponential-phase <italic>E. coli</italic> BW25113 strains (Keio collection), lower antibiotic concentrations, and short treatments (e.g., 1 hour)âwe first tested <italic>E. coli</italic> MG1655 WT, Î<italic>crp</italic>, and Î<italic>crp</italic> strains in late stationary phase using reduced antibiotic concentrations and shorter exposures. Both knockouts showed decreased survival following ampicillin and ofloxacin treatment compared to WT (see Figure 1-figure supplement 6), consistent with our findings in Figure 1 in the manuscript. In exponential phase, the knockout strains exhibited reduced survival after ampicillin treatment but increased survival after ofloxacin treatment relative to WT (see Author response image 2A below), again mirroring the trends in Figure 1. Gentamicin treatment, however, produced variable results in MG1655 knockouts, likely due to the brief 1-hour exposure being insufficient for robust conclusions (Author response image 2A). Notably, when we tested the corresponding Keio knockout strains in the BW25113 background, we observed increased tolerance in exponential-phase cells, reproducing Zeng et al.'s findings under their specific conditions (see Author response image 2B below), although BW25113 and MG1655 exhibited distinct persister phenotypes in exponential phase (Author response image 2A, B). These results, altogether, highlight the sensitivity of antibiotic tolerance and persistence phenotypes to factors such as strain background, antibiotic concentration, and treatment duration. This is now discussed in detail in the revised manuscript, with supporting data provided (see lines 460-476, and Supplement File 6, 7 in the current manuscript).</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><caption><title>Persister levels of <italic>E. coli</italic> K-12 MG1655 WT, Î<italic>crp</italic>, and Î<italic>crp</italic> strains in late stationary phase.</title><p>Cells were treated with ampicillin (5Ã MIC for 4 h), ofloxacin (5Ã MIC for 2.5 h), and gentamicin (3Ã MIC for 1 h). Concentrations and treatment durations were selected based on (Zeng et al., 2022).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-sa2-fig1-v1.tif"/></fig><fig id="sa2fig2" position="float"><label>Author response image 2.</label><caption><title>Persister levels of <italic>E. coli</italic> K-12 MG1655 (Panel A) and BW25113 (Panel B) WT, Î<italic>crp</italic>, and Î<italic>crp</italic> strains in the exponential growth phase.</title><p>Cells were treated at mid-exponential phase (OD<sub>600</sub> ~0.25) with ampicillin (5Ã MIC for 4 h), ofloxacin (5Ã MIC for 2.5 h), and gentamicin (3Ã MIC for 1 h). Treatment concentrations and durations were based on conditions described in (Zeng et al., 2022).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99735-sa2-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p><bold>Reviewer #3:</bold></p><p>The authors try to draw too many conclusions and it's difficult to identify what their actual findings are. For instance, they do not have any interesting findings with aminoglycosides but include the data and spend a lot of time discussing it, but it is really a distraction. The correlation between the induction of anabolic pathways in the crp mutant in the late stationary phase and the reduction in persisters is potentially very interesting but is buried in the paper with the vast quantities of data, and observations and conclusions that are often not well substantiated.</p></disp-quote><p>We thank the reviewer for their assessment that helped us clarify and strengthen the focus of our manuscript.</p><p>While our study is not focused on aminoglycosides, we believe the related data provide important insights into persister cell physiology. Persisters are traditionally described as metabolically dormant, non-growing cells. However, we consistently observe that aminoglycosidesâdespite requiring energy-dependent uptake and active protein translation for their activityâcan still eliminate persister cells in wild-type <italic>E. coli</italic>. This finding supports our central hypothesis that persisters may retain a basal level of metabolic activity sufficient to permit aminoglycoside uptake and action during prolonged treatment. We have revised the manuscript to present this point more clearly, ensuring it complements rather than distracts from the main narrative.</p><p>We respectfully emphasize that our conclusions are supported by multiple layers of evidence. Our metabolomics data are corroborated by proteomics and further validated by functional assays, including redox state measurements, growing versus non-growing cell detection, and targeted persister assays. In addition, we performed labor-intensive validations using individually selected Keio mutants treated with antibiotics to quantify persister levels, with key observations further confirmed in single-gene deletions in <italic>E. coli</italic> MG1655 strains.</p><p>We believe the revisions made in response to all reviewersâ comments have significantly improved the clarity, focus, and overall impact of the manuscript.</p><disp-quote content-type="editor-comment"><p>The discussion section is particularly difficult to read and I recommend a large overhaul to increase clarity. For instance, what are the authors trying to conclude in section (iii) of the discussion? That persisters in the stationary phase have higher energy than other cells? Is there data to support that? All sections are similarly lacking in clarity.</p></disp-quote><p>We repeatedly emphasize in the manuscript that while persister survival depends on energy metabolism, this does not imply that persisters have higher metabolic activity than those in the exponential growth phase. We have clarified this point in the revised manuscript (see lines 67-79, and 442-444 in the current manuscript).</p><disp-quote content-type="editor-comment"><p>The large number of mutants characterized is a strength, but the quality of the data provided for those experiments is poor. Did some of these mutants lose fitness in the deep stationary phase in the absence of antibiotics? Did some reach a far lower cfu/ml in the stationary phase? These details are important and without them, it is difficult to interpret the data.</p></disp-quote><p>Although metabolic mutations can affect cell growth, we do not observe substantial differences in cell numbers during the late stationary phase, when persister assays are performed. These knockout strains reach stationary phase fully by that time. We emphasize that we routinely measure cell numbers at this stage using flow cytometry before diluting cultures into fresh media and applying antibiotic treatments. Cell counts for the metabolic mutants are shown in Figure 5-figure supplement 4 in the current manuscript, and no significant growth deficiencies are observed in the late stationary phase. This is consistent with our previous publication (Shiraliyev &amp; Orman, 2023) and findings from Lewisâs group (Manuse et al., 2021), where similar knockout strains showed no drastic impact on growth.</p><disp-quote content-type="editor-comment"><p>There is an analysis of persister formation in mutants in the pts/CRP pathway that is not discussed (Zeng et al PNAS 2022, Parsons et al PNAS, 2024).</p></disp-quote><p>These studies are now cited and discussed in the revised manuscript (see lines 459-476).</p><disp-quote content-type="editor-comment"><p>The authors do not discuss ROS production and antibiotic killing in these experiments. Presumably, the WT would have a greater propensity to produce ROS in response to antibiotics than the crp mutant, but it survives better. Is ROS not involved in antibiotic killing in these conditions?</p></disp-quote><p>The experimental conditions used here are identical to those in our previously published study on persister cells in the late stationary phase (Orman &amp; Brynildsen, 2015), where we specifically investigated the role of ROS in antibiotic tolerance. In that work, we overexpressed key antioxidant enzymesâcatalases (<italic>katE</italic>, <italic>katG</italic>) and superoxide dismutases (<italic>sodA</italic>, <italic>sodB</italic> and <italic>sodC</italic>)âat stationary phase. These enzymes were confirmed to be catalytically active through functional assays, yet their overexpression had no measurable effect on persister levels. To further decouple ROS from respiratory activity in that study, we performed anaerobic experiments using nitrate as an alternative terminal electron acceptor. We found that anaerobic respiration actually enhanced persister formation, and inhibition of nitrate reductases using KCN reduced itâagain, independent of ROS. These findings provide compelling evidence that it is the respiratory activity itself, rather than ROS production, that influences persister formation in our system.</p><p>We have now included this discussion in the revised manuscript to clarify that ROS are unlikely to be a major factor in antibiotic killing under these conditions (see lines 503-513).</p><p>ReferencesAiba, H. (1985). Transcription of the <italic>Escherichia coli</italic> adenylate cyclase gene is negatively regulated by cAMP-cAMP receptor protein. The Journal of Biological Chemistry, 260(5), 3063â3070.</p><p>Amato, S. M., &amp; Brynildsen, M. P. (2015). Persister Heterogeneity Arising from a Single Metabolic Stress. Current Biology, 25(16), 2090â2098. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.cub.2015.06.034">https://doi.org/10.1016/j.cub.2015.06.034</ext-link></p><p>Amato, S. M., Orman, M. A., &amp; Brynildsen, M. P. (2013). Metabolic Control of Persister Formation in <italic>Escherichia coli</italic>. Molecular Cell, 50(4), 475â487. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/J.MOLCEL.2013.04.002">https://doi.org/10.1016/J.MOLCEL.2013.04.002</ext-link></p><p>Cui, P., Niu, H., Shi, W., Zhang, S., Zhang, H., Margolick, J., Zhang, W., &amp; Zhang, Y. (2016). Disruption of Membrane by Colistin Kills Uropathogenic <italic>Escherichia coli</italic> Persisters and Enhances Killing of Other Antibiotics. Antimicrobial Agents and Chemotherapy, 60(11), 6867â6871. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.01481-16">https://doi.org/10.1128/AAC.01481-16</ext-link></p><p>Hansen, S., Lewis, K., &amp; VuliÄ, M. (2008). Role of Global Regulators and Nucleotide Metabolism in Antibiotic Tolerance in <italic>Escherichia coli</italic>. Antimicrobial Agents and Chemotherapy, 52(8), 2718â2726. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.00144-08">https://doi.org/10.1128/AAC.00144-08</ext-link></p><p>Keseler, I. M., Collado-Vides, J., Santos-Zavaleta, A., Peralta-Gil, M., Gama-Castro, S., Muniz-Rascado, L., Bonavides-Martinez, C., Paley, S., Krummenacker, M., Altman, T., Kaipa, P., Spaulding, A., Pacheco, J., Latendresse, M., Fulcher, C., Sarker, M., Shearer, A. G., Mackie, A., Paulsen, I., â¦ Karp, P. D. (2011). EcoCyc: a comprehensive database of <italic>Escherichia coli</italic> biology. Nucleic Acids Research, 39(Database), D583âD590. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/nar/gkq1143">https://doi.org/10.1093/nar/gkq1143</ext-link></p><p>Kwan, B. W., Valenta, J. A., Benedik, M. J., &amp; Wood, T. K. (2013). Arrested protein synthesis increases persister-like cell formation. Antimicrobial Agents and Chemotherapy, 57(3), 1468â1473. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1128/AAC.02135-12">https://doi.org/10.1128/AAC.02135-12</ext-link></p><p>Leszczynska, D., Matuszewska, E., Kuczynska-Wisnik, D., Furmanek-Blaszk, B., &amp; Laskowska, E. (2013). The Formation of Persister Cells in Stationary-Phase Cultures of <italic>Escherichia coli</italic> Is Associated with the Aggregation of Endogenous Proteins. PLoS ONE, 8(1), e54737. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0054737">https://doi.org/10.1371/journal.pone.0054737</ext-link></p><p>Lin, J. S., Bekale, L. A., Molchanova, N., Nielsen, J. E., Wright, M., Bacacao, B., Diamond, G., Jenssen, H., Santa Maria, P. L., &amp; Barron, A. E. (2022). Anti-persister and Anti-biofilm Activity of Self-Assembled Antimicrobial Peptoid Ellipsoidal Micelles. ACS Infectious Diseases, 8(9), 1823â1830. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1021/acsinfecdis.2c00288">https://doi.org/10.1021/acsinfecdis.2c00288</ext-link></p><p>Majerfeld, I. H., Miller, D., Spitz, E., &amp; Rickenberg, H. V. (1981). Regulation of the synthesis of adenylate cyclase in <italic>Escherichia coli</italic> by the cAMP â cAMP receptor protein complex. Molecular and General Genetics MGG, 181(4), 470â475. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/BF00428738">https://doi.org/10.1007/BF00428738</ext-link></p><p>Manuse, S., Shan, Y., Canas-Duarte, S. J., Bakshi, S., Sun, W.-S., Mori, H., Paulsson, J., &amp; Lewis, K. (2021). Bacterial persisters are a stochastically formed subpopulation of low-energy cells. PLoS Biology, 19(4), e3001194.</p><p>Mok, W. W. K., Orman, M. A., &amp; Brynildsen, M. P. (2015). Impacts of global transcriptional regulators on persister metabolism. Antimicrobial Agents and Chemotherapy, 59(5), 2713â2719.</p><p>OFLOXACIN. (2019). <ext-link ext-link-type="uri" xlink:href="https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1779c568-d7bb-4bd5-bc29-13bd52ba8a0a&amp;type=display">https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1779c568-d7bb-4bd5-bc29-13bd52ba8a0a&amp;type=display</ext-link></p><p>Orman, M. A., &amp; Brynildsen, M. P. (2013). Dormancy is not necessary or sufficient for bacterial persistence. Antimicrobial Agents and Chemotherapy, 57(7), 3230â3239.</p><p>Orman, M. A., &amp; Brynildsen, M. P. (2015). Inhibition of stationary phase respiration impairs persister formation in <italic>E. coli</italic>. Nature Communications, 6(1), 7983.</p><p>Shah, D., Zhang, Z., Khodursky, A. B., Kaldalu, N., Kurg, K., &amp; Lewis, K. (2006). Persisters: a distinct physiological state of <italic>E. coli</italic>. BMC Microbiology, 6(1), 53. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/1471-2180-6-53">https://doi.org/10.1186/1471-2180-6-53</ext-link></p><p>Shiraliyev, R. C., &amp; Orman, M. (2023). Metabolic disruption impairs ribosomal protein levels, resulting in enhanced aminoglycoside tolerance. BioRxiv, 2012â2023.</p><p>Soto, E., Shoji, S., Muto, C., Tomono, Y., &amp; Marshall, S. (2014). Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: evaluation of the impact of renal impairment. British Journal of Clinical Pharmacology, 77(3), 509â521. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/bcp.12232">https://doi.org/10.1111/bcp.12232</ext-link></p><p>Zeng, J., Hong, Y., Zhao, N., Liu, Q., Zhu, W., Xiao, L., Wang, W., Chen, M., Hong, S., Wu, L., Xue, Y., Wang, D., Niu, J., Drlica, K., &amp; Zhao, X. (2022). A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade. Proceedings of the National Academy of Sciences, 119(23). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1073/pnas.2118566119">https://doi.org/10.1073/pnas.2118566119</ext-link></p></body></sub-article></article>